+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 51745

Chapter 51745 contains a list of PDF Full Texts available from EurekaMag.





Lin, A.; Rodriguez, F.J.; Karajannis, M.A.; Williams, S.C.; Legault, G.; Zagzag, D.; Burger, P.C.; Allen, J.C.; Eberhart, C.G.; Bar, E.E., 2012:
BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants

Pelizzo, M.Rosa.; Boschin, I.Merante.; Barollo, S.; Pennelli, G.; Toniato, A.; Zambonin, L.; Vianello, F.; Piotto, A.; Ide, E.Casal.; Pagetta, C.; Sorgato, N.; Torresan, F.; Girelli, M.Elisa.; Nacamulli, D.; Mantero, F.; Mian, C., 2011:
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience

Saroufim, M.; Habib, R.; Karram, S.; Youssef Massad, C.; Taraif, S.; Loya, A.; Houreih, M.Adib.; Sheikh, S.S.; Amr, S.S.; Satti, M.; Oberkanins, C.; Khalifeh, I., 2014:
BRAF analysis on a spectrum of melanocytic neoplasms: an epidemiological study across differing UV regions

Cohen, Y.; Goldenberg-Cohen, N.; Akrish, S.; Shani, T.; Amariglio, N.; Dratviman-Storobinsky, O.; Kaplan, I.; Barshack, I.; Hirshberg, A., 2013:
BRAF and GNAQ mutations in melanocytic tumors of the oral cavity

Massi, D.; Pinzani, P.; Simi, L.; Salvianti, F.; De Giorgi, V.; Pizzichetta, M.A.; Mirri, F.; Steffan, A.; Orlando, C.; Santucci, M.; Canzonieri, V., 2015:
BRAF and KIT somatic mutations are present in amelanotic melanoma

Chakrapani, A.; Warrick, A.; Nelson, D.; Beadling, C.; Corless, C.L., 2012:
BRAF and KRAS mutations in sporadic glomus tumors

Madureira, P.; de Mello, R.Andrade., 2015:
BRAF and MEK gene rearrangements in melanoma: implications for targeted therapy

Gargett, T.; Fraser, C.K.; Dotti, G.; Yvon, E.S.; Brown, M.P., 2015:
BRAF and MEK inhibition variably affect GD2-specific chimeric antigen receptor (CAR) T-cell function in vitro

Chiappetta, C.; Proietti, I.; Soccodato, V.; Puggioni, C.; Zaralli, R.; Pacini, L.; Porta, N.; Skroza, N.; Petrozza, V.; Potenza, C.; Della Rocca, C.; Di Cristofano, C., 2015:
BRAF and NRAS mutations are heterogeneous and not mutually exclusive in nodular melanoma

Makrodouli, E.; Oikonomou, E.; Koc, M.; Andera, L.; Sasazuki, T.; Shirasawa, S.; Pintzas, A., 2012:
BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study

Libra, M.; Torrisi, E., 2009:
BRAF and RKIP aberrations in actinic keratosis and non-melanoma skin cancers

Zaravinos, A.; Kanellou, P.; Baritaki, S.; Bonavida, B.; Spandidos, D.A., 2009:
BRAF and RKIP are significantly decreased in cutaneous squamous cell carcinoma

Jarkowski, A.; Khushalani, N.I., 2014:
BRAF and beyond: Tailoring strategies for the individual melanoma patient

Dienstmann, R.; Tabernero, J., 2011:
BRAF as a target for cancer therapy

Zambon, A.; Niculescu-Duvaz, D.; Niculescu-Duvaz, I.; Marais, R.; Springer, C.J., 2013:
BRAF as a therapeutic target: a patent review (2006 - 2012)

Wellbrock, C.; Hurlstone, A., 2010:
BRAF as therapeutic target in melanoma

Weisbart, R.H.; Chan, G.; Heinze, E.; Mory, R.; Nishimura, R.N.; Colburn, K., 2010:
BRAF drives synovial fibroblast transformation in rheumatoid arthritis

Rodriguez, F.J.; Ligon, A.H.; Horkayne-Szakaly, I.; Rushing, E.J.; Ligon, K.L.; Vena, N.; Garcia, D.I.; Cameron, J.Douglas.; Eberhart, C.G., 2012:
BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper

Hutchinson, K.E.; Lipson, D.; Stephens, P.J.; Otto, G.; Lehmann, B.D.; Lyle, P.L.; Vnencak-Jones, C.L.; Ross, J.S.; Pietenpol, J.A.; Sosman, J.A.; Puzanov, I.; Miller, V.A.; Pao, W., 2014:
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition

Corcoran, R.B.; Dias-Santagata, D.; Bergethon, K.; Iafrate, A.John.; Settleman, J.; Engelman, J.A., 2011:
BRAF gene amplification can promote acquired resistance to MEK inhibitors in cancer cells harboring the BRAF V600E mutation

Bai, J.; Zhang, W.; Zhou, D., 2015:
BRAF gene in hematological neoplasms

Lopes, J.Pedro.; Fonseca, E., 2013:
BRAF gene mutation in the natural history of papillary thyroid carcinoma: diagnostic and prognostic implications

Roa, Ián.; Game, A.; Bizama, C.; Schalper, K., 2014:
BRAF gene mutation in wild-type KRAS patients with colorectal cancers

Kadkhodazadeh, M.; Jafari, A.Reza.; Khalighi, H.Reza.; Ebadian, A.Reza.; Vaziri, S.; Amid, R., 2013:
BRAF gene polymorphism (rs10487888) assessment in chronic periodontitis and peri-implantitis in an Iranian population

Walts, A.E.; Pao, A.; Sacks, W.; Bose, S., 2014:
BRAF genetic heterogeneity in papillary thyroid carcinoma and its metastasis

Anonymous, 2015:
BRAF has a kinase-independent role in MAPK signaling

Salama, A.K.S.; Flaherty, K.T., 2014:
BRAF in melanoma: current strategies and future directions

Barollo, S.; Pennelli, G.; Vianello, F.; Watutantrige Fernando, S.; Negro, I.; Merante Boschin, I.; Pelizzo, M.Rosa.; Rugge, M.; Mantero, F.; Nacamulli, D.; Girelli, M.Elisa.; Busnardo, B.; Mian, C., 2010:
BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability

Kamata, T.; Hussain, J.; Giblett, S.; Hayward, R.; Marais, R.; Pritchard, C., 2010:
BRAF inactivation drives aneuploidy by deregulating CRAF

Steinberg, S.M.; Zhang, P.; Malik, B.T.; Boni, A.; Shabaneh, T.B.; Byrne, K.T.; Mullins, D.W.; Brinckerhoff, C.E.; Ernstoff, M.S.; Bosenberg, M.W.; Turk, M.Jo., 2015:
BRAF inhibition alleviates immune suppression in murine autochthonous melanoma

Margolin, K., 2012:
BRAF inhibition and beyond in advanced melanoma

Donia, M.; Fagone, P.; Nicoletti, F.; Andersen, R.Sick.; Høgdall, E.; Straten, P.Thor.; Andersen, M.Hald.; Svane, I.Marie., 2012:
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer

Dietrich, S.; Glimm, H.; Andrulis, M.; von Kalle, C.; Ho, A.D.; Zenz, T., 2012:
BRAF inhibition in refractory hairy-cell leukemia

Liu, C.; Peng, W.; Xu, C.; Lou, Y.; Zhang, M.; Wargo, J.A.; Chen, J.Qing.; Li, H.S.; Watowich, S.S.; Yang, Y.; Tompers Frederick, D.; Cooper, Z.A.; Mbofung, R.M.; Whittington, M.; Flaherty, K.T.; Woodman, S.E.; Davies, M.A.; Radvanyi, L.G.; Overwijk, W.W.; Lizée, G.; Hwu, P., 2013:
BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice

Frederick, D.T.; Piris, A.; Cogdill, A.P.; Cooper, Z.A.; Lezcano, C.; Ferrone, C.R.; Mitra, D.; Boni, A.; Newton, L.P.; Liu, C.; Peng, W.; Sullivan, R.J.; Lawrence, D.P.; Hodi, F.Stephen.; Overwijk, W.W.; Lizée, G.; Murphy, G.F.; Hwu, P.; Flaherty, K.T.; Fisher, D.E.; Wargo, J.A., 2013:
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma

Cooper, Z.A.; Frederick, D.T.; Juneja, V.R.; Sullivan, R.J.; Lawrence, D.P.; Piris, A.; Sharpe, A.H.; Fisher, D.E.; Flaherty, K.T.; Wargo, J.A., 2013:
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes

Wallach, J.B.; Rietschel, P.; Kalnicki, S.; Fox, J.L., 2015:
BRAF inhibitor (vemurafenib) concurrent with radiation therapy for metastatic melanoma producing severe skin and oral cavity reactions

Falchook, G.S.; Millward, M.; Hong, D.; Naing, A.; Piha-Paul, S.; Waguespack, S.G.; Cabanillas, M.E.; Sherman, S.I.; Ma, B.; Curtis, M.; Goodman, V.; Kurzrock, R., 2015:
BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancer

Anforth, R.; Fernandez-Penas, P., 2014:
BRAF inhibitor induced verrucal keratosis

Anonymous, 2015:
BRAF inhibitor resistance can be overcome by blocking autophagy

Rizos, H.; Menzies, A.M.; Pupo, G.M.; Carlino, M.S.; Fung, C.; Hyman, J.; Haydu, L.E.; Mijatov, B.; Becker, T.M.; Boyd, S.C.; Howle, J.; Saw, R.; Thompson, J.F.; Kefford, R.F.; Scolyer, R.A.; Long, G.V., 2014:
BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact

Bryant, C.J.; Keyse, S.M.; Caunt, C.J., 2016:
BRAF inhibitor resistance: are holidays and cocktails the answer?

Rahman, M.Atiqur.; Salajegheh, A.; Smith, R.Anthony.; Lam, A.King-yin., 2015:
BRAF inhibitor therapy for melanoma, thyroid and colorectal cancers: development of resistance and future prospects

Vultur, A.; Villanueva, J.; Herlyn, M., 2010:
BRAF inhibitor unveils its potential against advanced melanoma

Koya, R.C.; Mok, S.; Otte, N.; Blacketor, K.J.; Comin-Anduix, B.; Tumeh, P.C.; Minasyan, A.; Graham, N.A.; Graeber, T.G.; Chodon, T.; Ribas, A., 2012:
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy

Yaktapour, N.; Meiss, F.; Mastroianni, J.; Zenz, T.; Andrlova, H.; Mathew, N.R.; Claus, R.; Hutter, B.; Fröhling, S.; Brors, B.; Pfeifer, D.; Pantic, M.; Bartsch, I.; Spehl, T.S.; Meyer, P.T.; Duyster, J.; Zirlik, K.; Brummer, T.; Zeiser, R., 2015:
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia

Andrews, M.C.; Behren, A.; Chionh, F.; Mariadason, J.; Vella, L.J.; Do, H.; Dobrovic, A.; Tebbutt, N.; Cebon, J., 2014:
BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition

Flaherty, K.T., 2012:
BRAF inhibitors and melanoma

Nourry, A.; Zambon, A.; Davies, L.; Niculescu-Duvaz, I.; Dijkstra, H.P.; Ménard, D.; Gaulon, C.; Niculescu-Duvaz, D.; Suijkerbuijk, B.M.J.M.; Friedlos, F.; Manne, H.A.; Kirk, R.; Whittaker, S.; Marais, R.; Springer, C.J., 2010:
BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ring

Alcalá, A.Marzuka.; Flaherty, K.T., 2012:
BRAF inhibitors for the treatment of metastatic melanoma: clinical trials and mechanisms of resistance

Hertzman Johansson, C.; Egyhazi Brage, S., 2014:
BRAF inhibitors in cancer therapy

Morris, V.; Kopetz, S., 2013:
BRAF inhibitors in clinical oncology

Sanchez-Laorden, B.; Viros, A.; Girotti, M.Romina.; Pedersen, M.; Saturno, G.; Zambon, A.; Niculescu-Duvaz, D.; Turajlic, S.; Hayes, A.; Gore, M.; Larkin, J.; Lorigan, P.; Cook, M.; Springer, C.; Marais, R., 2014:
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling

Vin, H.; Ojeda, S.S.; Ching, G.; Leung, M.L.; Chitsazzadeh, V.; Dwyer, D.W.; Adelmann, C.H.; Restrepo, M.; Richards, K.N.; Stewart, L.R.; Du, L.; Ferguson, S.B.; Chakravarti, D.; Ehrenreiter, K.; Baccarini, M.; Ruggieri, R.; Curry, J.L.; Kim, K.B.; Ciurea, A.M.; Duvic, M.; Prieto, V.G.; Ullrich, S.E.; Dalby, K.N.; Flores, E.R.; Tsai, K.Y., 2013:
BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling

Chaminade, A.; Conte, H.; Jouary, T.; Fauconneau, A.; Darrigade, A-S.; Beylot-Barry, M.; Pham-Ledard, A., 2015:
BRAF inhibitors-induced panniculitis: a cutaneous side effect mimicking subcutaneous melanoma metastasis

Rahman, M.A.; Salajegheh, A.; Smith, R.A.; Lam, A.K-Y., 2014:
BRAF inhibitors: From the laboratory to clinical trials

Brower, V., 2010:
BRAF inhibitors: research accelerates in wake of positive findings

Zhang, L.; Singh, R.R.; Patel, K.P.; Stingo, F.; Routbort, M.; You, M.James.; Miranda, R.N.; Garcia-Manero, G.; Kantarjian, H.M.; Medeiros, L.Jeffrey.; Luthra, R.; Khoury, J.D., 2014:
BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS

Falchook, G.S.; Trent, J.C.; Heinrich, M.C.; Beadling, C.; Patterson, J.; Bastida, C.C.; Blackman, S.C.; Kurzrock, R., 2014:
BRAF mutant gastrointestinal stromal tumor: first report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance

Agretti, P.; Niccolai, F.; Rago, T.; De Marco, G.; Molinaro, A.; Scutari, M.; Di Cosmo, C.; Di Coscio, G.; Vitale, M.; Maccheroni, M.; Vitti, P.; Tonacchera, M., 2015:
BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency

Molinari, F.; Signoroni, S.; Lampis, A.; Bertan, C.; Perrone, F.; Sala, P.; Mondini, P.; Crippa, S.; Bertario, L.; Frattini, M., 2014:
BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines

Colanta, A.; Lin, O.; Tafe, L.; Ghossein, R.; Nafa, K.; Mitchell, T.; Ladanyi, M.; Arcila, M., 2013:
BRAF mutation analysis of fine-needle aspiration biopsies of papillary thyroid carcinoma: impact on diagnosis and prognosis

Richtig, E.; Schrama, D.; Ugurel, S.; Fried, I.; Niederkorn, A.; Massone, C.; Becker, J.C., 2013:
BRAF mutation analysis of only one metastatic lesion can restrict the treatment of melanoma: a case report

Hamilton, S.R., 2013:
BRAF mutation and microsatellite instability status in colonic and rectal carcinoma: context really does matter

Yi, W.; Zhong, D.; Zou, Q., 2013:
BRAF mutation and papillary thyroid cancer

Puxeddu, E.; Filetti, S., 2014:
BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?

Costa, A.M.; Herrero, Aín.; Fresno, M.F.; Heymann, J.; Alvarez, Jé.Antonio.; Cameselle-Teijeiro, J.; García-Rostán, G., 2007:
BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma

Ohori, N.Paul.; Singhal, R.; Nikiforova, M.N.; Yip, L.; Schoedel, K.E.; Coyne, C.; McCoy, K.L.; LeBeau, S.O.; Hodak, S.P.; Carty, S.E.; Nikiforov, Y.E., 2013:
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma

Dietel, M.; Enk, A.; Lehmann, A.; Bauer, J.; Garbe, C.; Kellner, U.; Kirchner, T.; Jung, A.; Kreipe, H.; Merkelbach-Bruse, S.; Büttner, R.; Rüschoff, J.; Schlake, W.; Schirmacher, P.; Penzel, R.; Stadler, R., 2012:
BRAF mutation detection in metastatic melanoma

Cipriani, N.A.; Letovanec, I.; Hornicek, F.J.; Mullen, J.T.; Duan, Z.; Borger, D.R.; Nielsen, G.Petur., 2015:
BRAF mutation in 'sarcomas': a possible method to detect de-differentiated melanomas

Zhou, Z-yong.; Han, Y.; Wang, L-ping., 2009:
BRAF mutation in colorectal serrated lesions

Marotta, V.; Sapio, M.Rosaria.; Guerra, A.; Vitale, M., 2011:
BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma

Moon, H.Jung.; Kim, E-Kyung.; Chung, W.Youn.; Shin, D.Yeob.; Kwak, J.Young., 2016:
BRAF mutation in fine-needle aspiration specimens as a potential predictor for persistence/recurrence in patients with classical papillary thyroid carcinoma larger than 10 mm at a BRAF mutation prevalent area

Chai, Y.Jun.; Kim, S-jin.; Kim, S.Chin.; Koo, D.Hoon.; Min, H.Sook.; Lee, K.Eun.; Kim, J-hoon.; Youn, Y-Kyu., 2015:
BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography

Tol, J.; Nagtegaal, I.D.; Punt, C.J.A., 2009:
BRAF mutation in metastatic colorectal cancer

Lee, S-Hyun.; Ahn, B-Kwon.; Baek, S-Uhn.; Chang, H-Kyung., 2014:
BRAF mutation in multiple primary cancer with colorectal cancer and stomach cancer

Tufano, R.P.; Teixeira, G.V.; Bishop, J.; Carson, K.A.; Xing, M., 2012:
BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis

Xing, M., 2007:
BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

Ito, Y.; Yoshida, H.; Maruo, R.; Morita, S.; Takano, T.; Hirokawa, M.; Yabuta, T.; Fukushima, M.; Inoue, H.; Tomoda, C.; Kihara, M.; Uruno, T.; Higashiyama, T.; Takamura, Y.; Miya, A.; Kobayashi, K.; Matsuzuka, F.; Miyauchi, A., 2008:
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients

Tang, K-Tsun.; Lee, C-Hsen., 2010:
BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications

Xing, M., 2009:
BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management

Cameselle-Teijeiro, Jé.; Abdulkader, I.; Pérez-Becerra, R.; Vázquez-Boquete, A.; Alberte-Lista, L.; Ruiz-Ponte, C.; Forteza, Jónimo.; Sobrinho-Simões, M., 2009:
BRAF mutation in solid cell nest hyperplasia associated with papillary thyroid carcinoma. A precursor lesion?

Thiel, A.; Heinonen, M.; Kantonen, J.; Gylling, A.; Lahtinen, L.; Korhonen, M.; Kytölä, S.; Mecklin, J-Pekka.; Orpana, A.; Peltomäki, Päivi.; Ristimäki, A., 2014:
BRAF mutation in sporadic colorectal cancer and Lynch syndrome

Bertelli, A.Augusto.T.; Gonçalves, A.José.; Menezes, M.B.; Melo, M.R.; Tincani, S.; Massarollo, L.Cláudio.Bosco., 2014:
BRAF mutation in the elderly submitted to thyroidectomy

Teng, H-Wei.; Huang, Y-Chung.; Lin, J-Kou.; Chen, W-Shone.; Lin, T-Chen.; Jiang, J-Kai.; Yen, C-Chuan.; Li, A.Fen-Yau.; Wang, H-Wei.; Chang, S-Ching.; Lan, Y-Tzu.; Lin, C-Chi.; Wang, H-Sheng.; Yang, S-Haur., 2012:
BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy

Zeppernick, F.; Ardighieri, L.; Hannibal, C.G.; Vang, R.; Junge, J.; Kjaer, S.K.; Zhang, R.; Kurman, R.J.; Shih, I-Ming., 2015:
BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors

Clancy, C.; Burke, J.P.; Kalady, M.F.; Coffey, J.C., 2014:
BRAF mutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysis

Ang, P.Woon.; Li, W.Qi.; Soong, R.; Iacopetta, B., 2009:
BRAF mutation is associated with the CpG island methylator phenotype in colorectal cancer from young patients

Shi, Y.; Li, J.; Wu, S-Yu.; Qin, L.; Jiao, Y-Fei., 2014:
BRAF mutation is associated with the unique morphology of traditional serrated adenoma of the colorectum

Wong, K-Kwok.; Tsang, Y.T.M.; Deavers, M.T.; Mok, S.C.; Zu, Z.; Sun, C.; Malpica, A.; Wolf, J.K.; Lu, K.H.; Gershenson, D.M., 2011:
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas

Han, S-Ah.; Park, W.Seo.; Jang, J-Hoon.; Min, S-Young.; Ryu, J.Kyu.; Song, J-Yoon., 2014:
BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer

Yaeger, R.; Cercek, A.; Chou, J.F.; Sylvester, B.E.; Kemeny, N.E.; Hechtman, J.F.; Ladanyi, M.; Rosen, N.; Weiser, M.R.; Capanu, M.; Solit, D.B.; D'Angelica, M.I.; Vakiani, E.; Saltz, L.B., 2014:
BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer

Mao, C.; Liao, R-Yan.; Chen, Q., 2010:
BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer

Phipps, A.I.; Buchanan, D.D.; Makar, K.W.; Burnett-Hartman, A.N.; Coghill, A.E.; Passarelli, M.N.; Baron, J.A.; Ahnen, D.J.; Win, A.Ko.; Potter, J.D.; Newcomb, P.A., 2012:
BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristics

Hostein, I.; Faur, N.; Primois, C.; Boury, Fédérique.; Denard, Jérome.; Emile, J-François.; Bringuier, P-Paul.; Scoazec, J-Yves.; Coindre, J-Michel., 2010:
BRAF mutation status in gastrointestinal stromal tumors

Miccoli, P.; Basolo, F., 2014:
BRAF mutation status in papillary thyroid carcinoma: significance for surgical strategy

Massad, C.; Loya, A.; Taraif, S.; Saroufim, M.; Kibbi, A.G.; Habib, R.; Novy, M.; Rauscher, B.; Oberkanins, C.; Khalifeh, I., 2015:
BRAF mutation status in primary and metastatic melanomas in two regions with differing potential ultraviolet radiation exposure

Barbour, A.P.; Tang, Y.Hang.; Armour, N.; Dutton-Regester, K.; Krause, L.; Loffler, K.A.; Lambie, D.; Burmeister, B.; Thomas, J.; Smithers, B.Mark.; Hayward, N.K., 2014:
BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy

Gonzalez, D.; Fearfield, L.; Nathan, P.; Tanière, P.; Wallace, A.; Brown, E.; Harwood, C.; Marsden, J.; Whittaker, S., 2013:
BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel

Imianitov, E.N., 2013:
BRAF mutation testing for the choice of melanoma treatment

Ziai, J.; Hui, P., 2012:
BRAF mutation testing in clinical practice

Sharma, S.G.; Gulley, M.L., 2010:
BRAF mutation testing in colorectal cancer

Weyant, G.W.; Wisotzkey, J.D.; Benko, F.A.; Donaldson, K.J., 2015:
BRAF mutation testing in solid tumors: a methodological comparison

Xing, M.; Clark, D.; Guan, H.; Ji, M.; Dackiw, A.; Carson, K.A.; Kim, M.; Tufaro, A.; Ladenson, P.; Zeiger, M.; Tufano, R., 2009:
BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer

Adeniran, A.J.; Hui, P.; Chhieng, D.C.; Prasad, M.L.; Schofield, K.; Theoharis, C., 2013:
BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance

Brick, K.E.; Halling, K.C.; Khan, Y.K.; Peters, M.S., 2013:
BRAF mutation-positive folliculotropic metastatic melanoma

Liu, D.; Xing, J.; Trink, B.; Xing, M., 2011:
BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus

Xu, X., 2012:
BRAF mutation: a double-edged sword in epigenetic alterations?

Arenbergerová, M.; Puzanov, I., 2012:
BRAF mutation: a novel approach in targeted melanoma therapy

Burger, J.A., 2012:
BRAF mutation: supporting diversity in HCL

Jakubowski, M.; Hunt, J.L., 2009 :
BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns

Ranjbari, N.; Almasi, S.; Mohammadi-Asl, J.; Rahim, F., 2013:
BRAF mutations in Iranian patients with papillary thyroid carcinoma

El-Osta, H.; Falchook, G.; Tsimberidou, A.; Hong, D.; Naing, A.; Kim, K.; Wen, S.; Janku, F.; Kurzrock, R., 2012:
BRAF mutations in advanced cancers: clinical characteristics and outcomes

Jebaraj, B.Michael.Chelliah.; Kienle, D.; Bühler, A.; Winkler, D.; Döhner, H.; Stilgenbauer, S.; Zenz, T., 2013:
BRAF mutations in chronic lymphocytic leukemia

Kalady, M.F.; Dejulius, K.L.; Sanchez, J.A.; Jarrar, A.; Liu, X.; Manilich, E.; Skacel, M.; Church, J.M., 2012:
BRAF mutations in colorectal cancer are associated with distinct clinical characteristics and worse prognosis

Yaeger, R.; Saltz, L., 2013:
BRAF mutations in colorectal cancer: clinical relevance and role in targeted therapy

Bauer, Jürgen.; Büttner, P.; Murali, R.; Okamoto, I.; Kolaitis, N.A.; Landi, M.T.; Scolyer, R.A.; Bastian, B.C., 2011:
BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site

Pardanani, A.; Tefferi, A., 2011:
BRAF mutations in hairy-cell leukemia

Takahashi, Y.; Mori, J.; Kami, M., 2011:
BRAF mutations in hairy-cell leukemia

Kanitakis, J.; Baldassini, S.; Lora, V.; Euvrard, S., 2010:
BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients

Ehsani, L.; Cohen, C.; Fisher, K.E.; Siddiqui, M.T., 2015:
BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression

Leonardi, G.Costanza.; Candido, S.; Carbone, M.; Raiti, F.; Colaianni, V.; Garozzo, S.; Cinà, D.; McCubrey, J.A.; Libra, M., 2013:
BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review)

Chen, D.; Zhang, L-Qun.; Huang, J-Fu.; Liu, K.; Chuai, Z-Ran.; Yang, Z.; Wang, Y-Xia.; Shi, D-Chuan.; Liu, Q.; Huang, Q.; Fu, W-Ling., 2015:
BRAF mutations in patients with non-small cell lung cancer: a systematic review and meta-analysis

Wójcik, P.; Okoń, K.; Osuch, Cław.; Klimkowska, A.; Tomaszewska, R., 2016:
BRAF mutations in sporadic colorectal carcinoma from polish patients

Hall, R.D.; Kudchadkar, R.R., 2015:
BRAF mutations: signaling, epidemiology, and clinical experience in multiple malignancies

Lea, A.; Allingham-Hawkins, D.; Levine, S., 2010:
BRAF p.Val600Glu (V600E) Testing for Assessment of Treatment Options in Metastatic Colorectal Cancer

Qiu, J.; Compagnone, M.; Laibe, S.; Lagarde, A.; Goncalves, A.; Turrini, O.; Xerri, L.; Monges, Gève.; Olschwang, S., 2011:
BRAF p.Val600Glu (V600E) somatic mutation is mainly associated with MSS phenotype in metastatic colorectal cancer

Olson, M.T.; Harrington, C.; Beierl, K.; Chen, G.; Thiess, M.; O'Neill, A.; Taube, J.M.; Zeiger, M.A.; Lin, M-Tseh.; Eshleman, J.R., 2014:
BRAF pyrosequencing analysis aided by a lookup table

Dhomen, N.; Marais, R., 2009:
BRAF signaling and targeted therapies in melanoma

Proietti, A.; Giannini, R.; Ugolini, C.; Miccoli, M.; Fontanini, G.; Di Coscio, G.; Romani, R.; Berti, P.; Miccoli, P.; Basolo, F., 2011:
BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features

Di Benedetto, G.; Fabozzi, A.; Rinaldi, C.; Rinaldi, C.Roberto., 2013:
BRAF test and cytological diagnosis with a single fine needle cytology sample

Phillips, B.; Kalady, M.; Kim, R., 2011:
BRAF testing in advanced colorectal cancer: is it ready for prime time?

Oikonomou, E.; Koustas, E.; Goulielmaki, M.; Pintzas, A., 2015:
BRAF vs RAS oncogenes: are mutations of the same pathway equal? Differential signalling and therapeutic implications

Pennelli, G.; Vianello, F.; Barollo, S.; Pezzani, R.; Merante Boschin, I.; Pelizzo, M.Rosa.; Mantero, F.; Rugge, M.; Mian, C., 2012:
BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma

Dahlman, K.Brown.; Xia, J.; Hutchinson, K.; Ng, C.; Hucks, D.; Jia, P.; Atefi, M.; Su, Z.; Branch, S.; Lyle, P.L.; Hicks, D.J.; Bozon, V.; Glaspy, J.A.; Rosen, N.; Solit, D.B.; Netterville, J.L.; Vnencak-Jones, C.L.; Sosman, J.A.; Ribas, A.; Zhao, Z.; Pao, W., 2013:
BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors

Cañadas Garre, M.; López de la Torre Casares, Mín.; Becerra Massare, P.; López Nevot, M.Ángel.; Villar Del Moral, Jús.; Muñoz Pérez, N.; Vílchez Joya, R.; Montes Ramírez, R.; Llamas Elvira, Jé.Manuel., 2011:
BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma

Hong, D.S.; Vence, L.; Falchook, G.; Radvanyi, L.G.; Liu, C.; Goodman, V.; Legos, J.J.; Blackman, S.; Scarmadio, A.; Kurzrock, R.; Lizee, G.; Hwu, P., 2012:
BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competency

Lebbé, C.; How-Kit, A.; Battistella, M.; Sadoux, A.; Podgorniak, M-Pierre.; Sidina, I.; Pages, Cécile.; Roux, J.; Porcher, R.; Tost, J.; Mourah, S., 2015:
BRAF(V600) mutation levels predict response to vemurafenib in metastatic melanoma

Nucera, C.; Lawler, J.; Parangi, S., 2011:
BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression

Guerra, A.; Di Stasi, V.; Zeppa, P.; Faggiano, A.; Marotta, V.; Vitale, M., 2014:
BRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay

Oikonomou, E.; Makrodouli, E.; Evagelidou, M.; Joyce, T.; Probert, L.; Pintzas, A., 2010:
BRAF(V600E) efficient transformation and induction of microsatellite instability versus KRAS(G12V) induction of senescence markers in human colon cancer cells

Patel, A.; Klubo-Gwiezdzinska, J.; Hoperia, V.; Larin, A.; Jensen, K.; Bauer, A.; Vasko, V., 2012:
BRAF(V600E) mutation analysis from May-Grünwald Giemsa-stained cytological samples as an adjunct in identification of high-risk papillary thyroid carcinoma

Ito, Y.; Yoshida, H.; Kihara, M.; Kobayashi, K.; Miya, A.; Miyauchi, A., 2014:
BRAF(V600E) mutation analysis in papillary thyroid carcinoma: is it useful for all patients?

Chang, H.; Lee, H.; Yoon, S.Och.; Kim, H.; Kim, A.; Kim, B-hui., 2012:
BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma

Durante, C.; Tallini, G.; Puxeddu, E.; Sponziello, M.; Moretti, S.; Ligorio, C.; Cavaliere, A.; Rhoden, K.J.; Verrienti, A.; Maranghi, M.; Giacomelli, L.; Russo, D.; Filetti, S., 2011:
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas

Elisei, R.; Ugolini, C.; Viola, D.; Lupi, C.; Biagini, A.; Giannini, R.; Romei, C.; Miccoli, P.; Pinchera, A.; Basolo, F., 2008:
BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

Kurtulmus, N.; Duren, M.; Ince, U.; Cengiz Yakicier, M.; Peker, O.; Aydın, O.; Altiok, E.; Giray, S.; Azizlerli, H., 2013:
BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness

Michonneau, D.; Kaltenbach, S.; Derrieux, C.; Trinquand, A.; Brouzes, C.; Gibault, L.; North, M-Odile.; Delarue, R.; Varet, B.; Emile, J-François.; Brousse, N.; Hermine, O., 2015:
BRAF(V600E) mutation in a histiocytic sarcoma arising from hairy cell leukemia

Arnhard, K.; Pitterl, F.; Sperner-Unterweger, B.; Fuchs, D.; Koal, T.; Oberacher, H., 2018:
A validated liquid chromatography-high resolution-tandem mass spectrometry method for the simultaneous quantitation of tryptophan, kynurenine, kynurenic acid, and quinolinic acid in human plasma

Jing, F-jing.; Liang, J.; Liang, Z-yong.; Meng, C.; Long, W.; Li, X-yi.; Lin, Y-song., 2014:
BRAF(V600E) mutation is not a positive predictor for distant metastasis in sporadic papillary thyroid carcinoma

Czajkowski, R., 2011:
BRAF, HRAS, KRAS, NRAS and CDKN2A genes analysis in cultured melanocytes used for vitiligo treatment

Velho, Sérgia.; Moutinho, Cátia.; Cirnes, Lís.; Albuquerque, C.; Hamelin, R.; Schmitt, F.; Carneiro, Fátima.; Oliveira, C.; Seruca, R., 2008:
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?

Da Forno, P.D.; Pringle, J.H.; Fletcher, A.; Bamford, M.; Su, L.; Potter, L.; Saldanha, G., 2009:
BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance

García-Casado, Z.; Traves, V.; Bañuls, J.; Niveiro, M.; Gimeno-Carpio, E.; Jimenez-Sanchez, A.I.; Moragón, M.; Onrubia, J.A.; Oliver, V.; Kumar, R.; Nagore, E., 2016:
BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma

Nichols, K.E.; Arceci, R.J., 2010:
BRAF, a piece of the LCH puzzle

Flaherty, K.T.; McArthur, G., 2010:
BRAF, a target in melanoma: implications for solid tumor drug development

Gauchotte, G.; Philippe, C.; Lacomme, Séphanie.; Léotard, B.; Wissler, M-Pierre.; Allou, L.; Toussaint, B.; Klein, M.; Vignaud, J-Michel.; Bressenot, A., 2011:
BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis

Machnicki, M.M.; Stoklosa, T., 2015:
BRAF--a new player in hematological neoplasms

Hawkins, C.; Walker, E.; Mohamed, N.; Zhang, C.; Jacob, K.; Shirinian, M.; Alon, N.; Kahn, D.; Fried, I.; Scheinemann, K.; Tsangaris, E.; Dirks, P.; Tressler, R.; Bouffet, E.; Jabado, N.; Tabori, U., 2011:
BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma

Mesko, S.M.; Rosenthal, K.J.; Boasberg, P.D.; Hamid, O., 2016:
BRAF-Targeted Therapy to Treat Superior Vena Cava Syndrome in a Patient With Metastatic Cancer

Meckbach, D.; Keim, U.; Richter, S.; Leiter, U.; Eigentler, T.K.; Bauer, Jürgen.; Pflugfelder, A.; Büttner, P.; Garbe, C.; Weide, B., 2015:
BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy

Dahiya, S.; Emnett, R.J.; Haydon, D.H.; Leonard, J.R.; Phillips, J.J.; Perry, A.; Gutmann, D.H., 2014:
BRAF-V600E mutation in pediatric and adult glioblastoma

Wang, Y.; Guo, Q.; Zhao, Y.; Chen, J.; Wang, S.; Hu, J.; Sun, Y., 2014:
BRAF-activated long non-coding RNA contributes to cell proliferation and activates autophagy in papillary thyroid carcinoma

Guo, Q.; Zhao, Y.; Chen, J.; Hu, J.; Wang, S.; Zhang, D.; Sun, Y., 2014:
BRAF-activated long non-coding RNA contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition

Landau, M.S.; Kuan, S-Fan.; Chiosea, S.; Pai, R.K., 2014:
BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression

Koelsche, C.; Sahm, F.; Wöhrer, A.; Jeibmann, A.; Schittenhelm, J.; Kohlhof, P.; Preusser, M.; Romeike, B.; Dohmen-Scheufler, H.; Hartmann, C.; Mittelbronn, M.; Becker, A.; von Deimling, A.; Capper, D., 2014:
BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression

Pai, R.K.; Jayachandran, P.; Koong, A.C.; Chang, D.T.; Kwok, S.; Ma, L.; Arber, D.A.; Balise, R.R.; Tubbs, R.R.; Shadrach, B.; Pai, R.K., 2012:
BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features

Ho, P-Chih.; Kaech, S.M., 2014:
BRAF-targeted therapy alters the functions of intratumoral CD4 + T cells to inhibit melanoma progression

Ngiow, S.Foong.; Knight, D.A.; Ribas, A.; McArthur, G.A.; Smyth, M.J., 2013:
BRAF-targeted therapy and immune responses to melanoma

Cornejo, K.M.; Hutchinson, L.; Deng, A.; Tomaszewicz, K.; Welch, M.; Lyle, S.; Dresser, K.; Cosar, E.F., 2014:
BRAF/KRAS gene sequencing of sebaceous neoplasms after mismatch repair protein analysis

Ranzani, M.; Alifrangis, C.; Perna, D.; Dutton-Regester, K.; Pritchard, A.; Wong, K.; Rashid, M.; Robles-Espinoza, C.Daniela.; Hayward, N.K.; McDermott, U.; Garnett, M.; Adams, D.J., 2015:
BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib

Mar, V.J.; Wong, S.Q.; Li, J.; Scolyer, R.A.; McLean, C.; Papenfuss, A.T.; Tothill, R.W.; Kakavand, H.; Mann, G.J.; Thompson, J.F.; Behren, A.; Cebon, J.S.; Wolfe, R.; Kelly, J.W.; Dobrovic, A.; McArthur, G.A., 2014:
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage

Rustgi, A.K., 2013:
BRAF: a driver of the serrated pathway in colon cancer

Dutenhefner, S.E.; Marui, S.; Santos, A.B.O.; de Lima, E.Urbano.; Inoue, M.; Neto, J.S.Brandão.; Shiang, C.; Fukushima, J.T.; Cernea, C.R.; Friguglietti, C.U.M., 2014:
BRAF: a tool in the decision to perform elective neck dissection?

Sabourin, J-Christophe., 2014:
BRAF: the pathologist's favorite oncogene

Hoekstra, J.; Hart, A.; Boobis, A.; Claupein, E.; Cockburn, A.; Hunt, A.; Knudsen, I.; Richardson, D.; Schilter, Bît.; Schütte, K.; Torgerson, P.R.; Verhagen, H.; Watzl, B.; Chiodini, A., 2013:
BRAFO tiered approach for Benefit-Risk Assessment of Foods

Silva, J.M.; Bulman, C.; McMahon, M., 2015:
BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation

Pinzani, P.; Santucci, C.; Mancini, I.; Simi, L.; Salvianti, F.; Pratesi, N.; Massi, D.; De Giorgi, V.; Pazzagli, M.; Orlando, C., 2012:
BRAFV600E detection in melanoma is highly improved by COLD-PCR

Toon, C.W.; Walsh, M.D.; Chou, A.; Capper, D.; Clarkson, A.; Sioson, L.; Clarke, S.; Mead, S.; Walters, R.J.; Clendenning, M.; Rosty, C.; Young, J.P.; Win, A.Ko.; Hopper, J.L.; Crook, A.; von Deimling, A.; Jenkins, M.A.; Buchanan, D.D.; Gill, A.J., 2013:
BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome

Sahm, F.; Capper, D.; Preusser, M.; Meyer, J.; Stenzinger, A.; Lasitschka, F.; Berghoff, A-Sophie.; Habel, A.; Schneider, M.; Kulozik, A.; Anagnostopoulos, I.; Müllauer, L.; Mechtersheimer, G.; von Deimling, A., 2012:
BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis

Ilie, M.I.; Long-Mira, E.; Hofman, Véronique.; Mouroux, Jérôme.; Vignaud, J-Michel.; Gauchotte, G.; Begueret, H.; Merlio, J-Philippe.; Emile, J-François.; Hébuterne, X.; Hofman, P., 2015:
BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer

Kim, S.Wook.; Lee, J.In.; Kim, J-Won.; Ki, C-Seok.; Oh, Y.Lyun.; Choi, Y-La.; Shin, J.Hee.; Kim, H.Kyung.; Jang, H.Won.; Chung, J.Hoon., 2010:
BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population

Saridaki, Z.; Tzardi, M.; Sfakianaki, M.; Papadaki, C.; Voutsina, A.; Kalykaki, A.; Messaritakis, I.; Mpananis, K.; Mavroudis, D.; Stathopoulos, E.; Georgoulias, V.; Souglakos, J., 2014:
BRAFV600E mutation analysis in patients with metastatic colorectal cancer (mCRC) in daily clinical practice: correlations with clinical characteristics, and its impact on patients' outcome

Gu, L-Qun.; Li, F-Ying.; Zhao, L.; Liu, Y.; Zang, X-Xiong.; Wang, T-Xiang.; Chen, H-Ping.; Ning, G.; Zhao, Y-Ju., 2009:
BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma

Chen, D.; Huang, J-Fu.; Liu, K.; Zhang, L-Qun.; Yang, Z.; Chuai, Z-Ran.; Wang, Y-Xia.; Shi, D-Chuan.; Huang, Q.; Fu, W-Ling., 2014:
BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis

Xing, M., 2012:
BRAFV600E mutation and papillary thyroid cancer: chicken or egg?

Yang, K.; Wang, H.; Liang, Z.; Liang, J.; Li, F.; Lin, Y., 2015:
BRAFV600E mutation associated with non-radioiodine-avid status in distant metastatic papillary thyroid carcinoma

Sancisi, V.; Nicoli, D.; Ragazzi, M.; Piana, S.; Ciarrocchi, A., 2012:
BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas

Ahn, D.; Park, J.Sik.; Sohn, J.Ho.; Kim, J.Hyug.; Park, S-Kyun.; Seo, A.Na.; Park, J.Young., 2012:
BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma

Varga, E.; Korom, I.; Polyánka, H.; Szabó, K.; Széll, M.; Baltás, E.; Bata-Csörgő, Z.; Kemény, L.; Oláh, J., 2016:
BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis

Lee, J.In.; Jang, H.Won.; Kim, S.Wook.; Kim, J-Won.; Oh, Y.Lyun.; Chung, J.Hoon., 2013:
BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas

Hirbe, A.C.; Pekmezci, M.; Dahiya, S.; Apicelli, A.J.; Van Tine, B.A.; Perry, A.; Gutmann, D.H., 2014:
BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors

Sykorova, V.; Dvorakova, S.; Ryska, A.; Vcelak, J.; Vaclavikova, E.; Laco, J.; Kodetova, D.; Kodet, R.; Cibula, A.; Duskova, J.; Hlobilkova, A.; Astl, J.; Vesely, D.; Betka, J.; Hoch, J.; Smutny, S.; Cap, J.; Vlcek, P.; Novak, Z.; Bendlova, B., 2010:
BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic

McClenahan, P.; Lin, L.L.; Tan, J-Marie.; Flewell-Smith, R.; Schaider, H.; Jagirdar, K.; Atkinson, V.; Lambie, D.; Prow, T.W.; Sturm, R.A.; Soyer, H.Peter., 2015:
BRAFV600E mutation status of involuting and stable nevi in dabrafenib therapy with or without trametinib

Kwak, J.Young.; Han, K.Hwa.; Yoon, J.Hyun.; Kim, E-Kyung.; Moon, H.Jung.; Kim, Y-Li.; Park, S-Jin.; Choi, J.Rak., 2013:
BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR

Bommarito, A.; Richiusa, P.; Carissimi, E.; Pizzolanti, G.; Rodolico, V.; Zito, G.; Criscimanna, A.; Di Blasi, F.; Pitrone, M.; Zerilli, M.; Amato, M.C.; Spinelli, G.; Carina, V.; Modica, G.; Latteri, M.Adelfio.; Galluzzo, A.; Giordano, C., 2012:
BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy

Schrama, D.; Keller, G.; Houben, R.; Ziegler, C.G.; Vetter-Kauczok, C.S.; Ugurel, S.; Becker, Jürgen.C., 2008:
BRAFV600E mutations in malignant melanoma are associated with increased expressions of BAALC

Chen, B.; Tardell, C.; Higgins, B.; Packman, K.; Boylan, J.F.; Niu, H., 2013:
BRAFV600E negatively regulates the AKT pathway in melanoma cell lines

Flockhart, R.J.; Webster, D.E.; Qu, K.; Mascarenhas, N.; Kovalski, J.; Kretz, M.; Khavari, P.A., 2012:
BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration

Zheng, X.; Xia, T.; Lin, L.; Gao, S.; Lee, Y.; Yu, Y.; Wei, S.; Gao, M., 2013:
BRAFV600E status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China

Johnson, D.B.; Sosman, J.A., 2015:
BRAFV600E-mutant melanoma presenting with cardiac involvement

Cangi, M.Giulia.; Biavasco, R.; Cavalli, G.; Grassini, G.; Dal-Cin, E.; Campochiaro, C.; Guglielmi, B.; Berti, A.; Lampasona, V.; von Deimling, A.; Sabbadini, M.Grazia.; Ferrarini, M.; Doglioni, C.; Dagna, L., 2016:
BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease

Cantwell-Dorris, E.R.; O'Leary, J.J.; Sheils, O.M., 2011:
BRAFV600E: implications for carcinogenesis and molecular therapy

Moravec, R.; Conger, K.K.; D'Souza, R.; Allison, A.B.; Casanova, J.E., 2012:
BRAG2/GEP100/IQSec1 interacts with clathrin and regulates α5β1 integrin endocytosis through activation of ADP ribosylation factor 5 (Arf5)

Fitzjohn, S.M.; Bashir, Z.I., 2010:
BRAGging about mechanisms of long-term depression

Archacki, R.; Buszewicz, D.; Sarnowski, T.J.; Sarnowska, E.; Rolicka, A.T.; Tohge, T.; Fernie, A.R.; Jikumaru, Y.; Kotlinski, M.; Iwanicka-Nowicka, R.; Kalisiak, K.; Patryn, J.; Halibart-Puzio, J.; Kamiya, Y.; Davis, S.J.; Koblowska, M.K.; Jerzmanowski, A., 2013:
BRAHMA ATPase of the SWI/SNF chromatin remodeling complex acts as a positive regulator of gibberellin-mediated responses in arabidopsis

Anonymous, 2010:
BRAILLE programs for the blind

Dittwald, P.; Valkenborg, D., 2014:
BRAIN 2.0: time and memory complexity improvements in the algorithm for calculating the isotope distribution

Berry, R.J., 1932:
BRAIN STRUCTURE IN RELATION TO THE MIND: Illustrated by new and original models

Pettigrew, R.Ivan., 2015:
BRAIN initiative to transform human imaging

Dittwald, P.; Claesen, Jürgen.; Burzykowski, T.; Valkenborg, D.; Gambin, A., 2013:
BRAIN: a universal tool for high-throughput calculations of the isotopic distribution for mass spectrometry

Church, G.M., 2014:
BRAIN: innovative neurotechnologies for imaging and therapeutics

Ozawa, S.; Kato, Y.; Kubota, E.; Hata, R-Ichiro., 2010:
BRAK/CXCL14 expression in oral carcinoma cells completely suppresses tumor cell xenografts in SCID mouse

González-Grandío, E.; Poza-Carrión, César.; Sorzano, C.Oscar.S.; Cubas, P., 2014:
BRANCHED1 promotes axillary bud dormancy in response to shade in Arabidopsis

Kasili, R.; Huang, C-Chun.; Walker, J.D.; Simmons, L.Alice.; Zhou, J.; Faulk, C.; Hülskamp, M.; Larkin, J.C., 2011:
BRANCHLESS TRICHOMES links cell shape and cell cycle control in Arabidopsis trichomes

Liao, Y-Chu.; Wang, Y-Song.; Guo, Y-Cherng.; Ozaki, K.; Tanaka, T.; Lin, H-Fen.; Chang, M-Hong.; Chen, K-Chung.; Yu, M-Lung.; Sheu, S-Hsiung.; Juo, S-Hang.Hank., 2012:
BRAP Activates Inflammatory Cascades and Increases the Risk for Carotid Atherosclerosis

Allali, J.; Saule, Cédric.; Chauve, Cédric.; d'Aubenton-Carafa, Y.; Denise, A.; Drevet, C.; Ferraro, P.; Gautheret, D.; Herrbach, C.; Leclerc, F.; de Monte, A.; Ouangraoua, A.; Sagot, M-France.; Termier, M.; Thermes, C.; Touzet, Hélène., 2012:
BRASERO: A Resource for Benchmarking RNA Secondary Structure Comparison Algorithms

Hu, Y.; Yu, D., 2015:
BRASSINOSTEROID INSENSITIVE2 interacts with ABSCISIC ACID INSENSITIVE5 to mediate the antagonism of brassinosteroids to abscisic acid during seed germination in Arabidopsis

Tanaka, A.; Nakagawa, H.; Tomita, C.; Shimatani, Z.; Ohtake, M.; Nomura, T.; Jiang, C-Jie.; Dubouzet, J.G.; Kikuchi, S.; Sekimoto, H.; Yokota, T.; Asami, T.; Kamakura, T.; Mori, M., 2009:
BRASSINOSTEROID UPREGULATED1, encoding a helix-loop-helix protein, is a novel gene involved in brassinosteroid signaling and controls bending of the lamina joint in rice

So, E.Young.; Ouchi, T., 2015:
BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunction

Harris, E.Y.; Ponts, N.; Levchuk, A.; Roch, K.Le.; Lonardi, S., 2010:
BRAT: bisulfite-treated reads analysis tool

Fuentes-Felix, C., 2003:
BRAVA: Results did not meet expectations

Bosiers, M.; Deloose, K.; Callaert, J.; Verbist, J.; Keirse, K.; Peeters, P., 2012:
BRAVISSIMO study: 12-month results from the TASC A/B subgroup

Bosiers, M.; Deloose, K.; Callaert, J.; Maene, L.; Beelen, R.; Keirse, K.; Verbist, J.; Peeters, P.; Schroë, H.; Lauwers, G.; Lansink, W.; Vanslembroeck, K.; D'archambeau, O.; Hendriks, J.; Lauwers, P.; Vermassen, F.; Randon, C.; Van Herzeele, I.; De Ryck, F.; De Letter, J.; Lanckneus, M.; Van Betsbrugge, M.; Thomas, B.; Deleersnijder, R.; Vandekerkhof, J.; Baeyens, I.; Berghmans, T.; Buttiens, J.; Van Den Brande, P.; Debing, E.; Rabbia, C.; Ruffino, A.; Tealdi, D.; Nano, G.; Stegher, S.;, 2013:
BRAVISSIMO: 12-month results from a large scale prospective trial

Figueroa, M.S.; Ruiz Moreno, J.M., 2014:
BRAVO and CRUISE: ranibizumab for the treatment of macular edema secondary to retinal vein occlusion

Hess, T.; Hahn, E.G.; Konturek, P.C., 2009:
BRAVO wireless 48 hour pH-metric system

Anonymous, 1948:
BRAZIL'S new school of nursing

Zhao, Y.; Simon, R., 2008:
BRB-ArrayTools Data Archive for human cancer gene expression: a unique and efficient data sharing resource

Elnour, A.M.; Elderdery, A.Y.; Mills, J.; Mohammed, B.A.; Elbietabdelaal, D.; Mohamed, A.Osman.; Elhassan, K.Eldin.H.; A, A.Hady.; Wahab, A.; Cooper, A., 2012:
BRCA 1 & 2 mutations in Sudanese secondary school girls with known breast cancer in their families

Habibović, S.; Hrgović, Z., 2009:
BRCA 1 and BRCA 2 gens in breast cancer

Burgess, M.; Puhalla, S., 2014:
BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different

Kent, A., 2011:
BRCA Mutation Carriers

Brankovic-Magic, M., 2006:
BRCA Testing in Serbia and Montenegro

George, S.H.L.; Shaw, P., 2014:
BRCA and Early Events in the Development of Serous Ovarian Cancer

Trainer, A.H.; Thompson, E.; James, P.A., 2012:
BRCA and beyond: a genome-first approach to familial breast cancer risk assessment

Brennan, G.T.; Relias, V.; Saif, M.Wasif., 2014:
BRCA and pancreatic cancer

Kim, R.; Byer, J.; Saif, M.Wasif., 2012:
BRCA and pancreatic cancer: selection of chemotherapy

Quinn, G.P.; Vadaparampil, S.T.; Tollin, S.; Miree, C.A.; Murphy, D.; Bower, B.; Silva, C., 2010:
BRCA carriers' thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none

Finch, A.; Evans, G.; Narod, S.A., 2012:
BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations

Murphy, C.G.; Moynahan, M.Ellen., 2010:
BRCA gene structure and function in tumor suppression: a repair-centric perspective

Muggia, F.; Safra, T.; Dubeau, L., 2011:
BRCA genes: lessons learned from experimental and clinical cancer

Sussner, K.M.; Edwards, T.; Villagra, C.; Rodriguez, M.Carina.; Thompson, H.S.; Jandorf, L.; Valdimarsdottir, H.B., 2016:
BRCA genetic counseling among at-risk Latinas in New York City: new beliefs shape new generation

Kelly, P.A.; Connors, L.M., 2014:
BRCA genetic testing: State of the science

Wasserman, L., 2014:
BRCA genetic testing: an RN's personal story

Ferrone, C.R.; Levine, D.A.; Tang, L.H.; Allen, P.J.; Jarnagin, W.; Brennan, M.F.; Offit, K.; Robson, M.E., 2008:
BRCA germline mutations in Jewish patients with pancreatic adenocarcinoma

Lavie, O.; Ben-Arie, A.; Segev, Y.; Faro, J.; Barak, F.; Haya, N.; Auslender, R.; Gemer, O., 2011:
BRCA germline mutations in women with uterine serous carcinoma--still a debate

Balmaña, J.; Díez, O.; Rubio, I.T.; Cardoso, F., 2011:
BRCA in breast cancer: ESMO Clinical Practice Guidelines

Balmaña, J.; Díez, O.; Castiglione, M., 2010:
BRCA in breast cancer: ESMO clinical recommendations

Diamond, J.R.; Borges, V.F.; Eckhardt, S.Gail.; Jimeno, A., 2010:
BRCA in breast cancer: from risk assessment to therapeutic prediction

Michaelson-Cohen, R.; Mor, P.; Srebnik, N.; Beller, U.; Levy-Lahad, E.; Eldar-Geva, T., 2014:
BRCA mutation carriers do not have compromised ovarian reserve

Alsop, K.; Fereday, S.; Meldrum, C.; deFazio, A.; Emmanuel, C.; George, J.; Dobrovic, A.; Birrer, M.J.; Webb, P.M.; Stewart, C.; Friedlander, M.; Fox, S.; Bowtell, D.; Mitchell, G., 2012:
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group

Smith, K.Lisa.; Isaacs, C., 2012:
BRCA mutation testing in determining breast cancer therapy

Bakos, A.D.; Hutson, S.P.; Loud, J.T.; Peters, J.A.; Giusti, R.M.; Greene, M.H., 2008:
BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience

Santoro, N., 2013:
BRCA mutations and fertility: do not push the envelope!

Safra, T.; Lai, W.C.; Borgato, L.; Nicoletto, M.O.; Berman, T.; Reich, E.; Alvear, M.; Haviv, I.; Muggia, F.M., 2014:
BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups

West, J.G.; Weitzel, J.N.; Tao, M.Lin.; Carpenter, M.; West, J.E.; Fanning, C., 2009:
BRCA mutations and the risk of angiosarcoma after breast cancer treatment

Olmos, D.; Castro, E., 2014:
BRCA mutations in prostate cancer patients

Smith, K.Lisa.; Adank, M.; Kauff, N.; Lafaro, K.; Boyd, J.; Lee, J.B.; Hudis, C.; Offit, K.; Robson, M., 2007:
BRCA mutations in women with ductal carcinoma in situ

Devi, S., 2012:
BRCA patent dispute may head to US Supreme Court

Anonymous, 2008:
BRCA screening

Pal, T.; Bonner, D.; Cragun, D.; Johnson, S.; Akbari, M.; Servais, L.; Narod, S.; Vadaparampil, S., 2013:
BRCA sequencing and large rearrangement testing in young Black women with breast cancer

Hottenrott, C., 2012:
BRCA testing changes decision on breast cancer surgery but evidence for benefit is still scarce

Anderson, B.O.; Javid, S.H.; Calhoun, K.E.; Byrd, D.R., 2012:
BRCA testing is important for our patients

Van Riel, E.; Wárlám-Rodenhuis, C.C.; Verhoef, S.; Rutgers, E.J.T.H.; Ausems, M.G.E.M., 2010:
BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing

Crum, C.P.; McKeon, F.D.; Xian, W., 2012:
BRCA, the oviduct, and the space and time continuum of pelvic serous carcinogenesis

Stagnaro, S.; Caramel, S., 2013:
BRCA-1 and BRCA-2 mutation bedside detection and breast cancer clinical primary prevention

Cannistra, S.A., 2007:
BRCA-1 in sporadic epithelial ovarian cancer: lessons learned from the genetics of hereditary disease

Foedermayr, M.; Sebesta, M.; Rudas, M.; Berghoff, A.S.; Promberger, R.; Preusser, M.; Dubsky, P.; Fitzal, F.; Gnant, M.; Steger, G.G.; Weltermann, A.; Zielinski, C.C.; Zach, O.; Bartsch, R., 2014:
BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

Litman, R.; Gupta, R.; Brosh, R.M.; Cantor, S.B., 2008:
BRCA-FA pathway as a target for anti-tumor drugs

Ma, C.; Chen, H-I.; Flores, M.; Huang, Y.; Chen, Y., 2014:
BRCA-Monet: a breast cancer specific drug treatment mode-of-action network for treatment effective prediction using large scale microarray database

Girolimetti, G.; Perrone, A.Myriam.; Santini, D.; Barbieri, E.; Guerra, F.; Ferrari, S.; Zamagni, C.; De Iaco, P.; Gasparre, G.; Turchetti, D., 2015:
BRCA-associated ovarian cancer: from molecular genetics to risk management

Leung, K.; Saif, M.Wasif., 2013:
BRCA-associated pancreatic cancer: the evolving management

Sahin, I.; Ararat, E.; Altundag, K., 2011:
BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes?

Muggia, F., 2009:
BRCA-deficient animal models and cisplatin resistance

Webb, E., 2014:
BRCA-negative women from BRCA-positive families may still be at increased risk of developing breast cancer

Li, W-Feng.; Hu, Z.; Zhang, B.; Cao, M-Zhi.; Wang, Y-Sheng.; Liu, X-Yi.; Zhao, L.; Liu, Y-Bing.; Yuan, W-Tao.; Shen, Z-Zhou.; Huang, W.; Shao, Z-Min., 2007:
BRCA1 1100delAT is a recurrent mutation in Chinese women with familial breast cancer

Yang, E.S.; Xia, F., 2010:
BRCA1 16 years later: DNA damage-induced BRCA1 shuttling

Thompson, M.E., 2010:
BRCA1 16 years later: an overview

Thompson, M.E., 2010:
BRCA1 16 years later: nuclear import and export processes

Linger, R.J.; Kruk, P.A., 2010:
BRCA1 16 years later: risk-associated BRCA1 mutations and their functional implications

O'Donnell, J.D.; Linger, R.J.; Kruk, P.A., 2010:
BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells

O'Donnell, J.D.; Johnson, N.C.; Turbeville, T.D.; Alfonso, M.Y.; Kruk, P.A., 2008:
BRCA1 185delAG truncation protein, BRAt, amplifies caspase-mediated apoptosis in ovarian cells

Alansari, A.S.; Al-Moundhri, M.; Al-Nabhani, M.M.; Al-Zidjali, S.A., 2008:
BRCA1 2080insA mutation in familial breast cancer

Krylova, N.Yu.; Lobeiko, O.S.; Sokolenko, A.P.; Iyevleva, A.G.; Rozanov, M.E.; Mitiushkina, N.V.; Gergova, M.M.; Porhanova, T.V.; Urmancheyeva, A.F.; Maximov, S.Ya.; Togo, A.V.; Imyanitov, E.N., 2006:
BRCA1 4153delA founder mutation in Russian ovarian cancer patients

Quaresima, B.; Romeo, F.; Faniello, M.C.; Di Sanzo, M.; Liu, C-Gong.; Lavecchia, A.; Taccioli, C.; Gaudio, E.; Baudi, F.; Trapasso, F.; Croce, C.M.; Cuda, G.; Costanzo, F., 2008:
BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo

Infante, M.; Durán, M.; Acedo, A.; Pérez-Cabornero, L.; Sanz, D.J.; García-González, M.; Beristain, E.; Esteban-Cardeñosa, E.; de la Hoya, M.; Teulé, A.; Vega, A.; Tejada, M-I.; Lastra, E.; Miner, C.; Velasco, E.A., 2010:
BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin

Solano, A.Rosaria.; Aceto, G.Maria.; Delettieres, D.; Veschi, S.; Neuman, M.Isabel.; Alonso, E.; Chialina, S.; Chacón, R.Daniel.; Renato, M-Costantini.; Podestá, E.Jorge., 2012:
BRCA1 And BRCA2 analysis of Argentinean breast/ovarian cancer patients selected for age and family history highlights a role for novel mutations of putative south-American origin

Harris, J.L.; Khanna, K.Kum., 2011:
BRCA1 A‐complex fine tunes repair functions of BRCA1

Veeck, J.; Ropero, S.; Setien, F.; Gonzalez-Suarez, E.; Osorio, A.; Benitez, J.; Herman, J.G.; Esteller, M., 2010:
BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors

Rosen, E.M.; Ma, Y.; Fan, S., 2016:
BRCA1 Cross-Talk with Hormone Receptors

Martin, S.Eric.; Sausen, M.; Joseph, A.; Biggs, D.D.; Kingham, B.F.; Martin, E.S., 2008:
BRCA1 E1644X: a deleterious mutation in an African American individual with early onset breast cancer

Tammaro, C.; Raponi, M.; Wilson, D.I.; Baralle, D., 2015:
BRCA1 EXON 11, a CERES (composite regulatory element of splicing) element involved in splice regulation

Horiuchi, A.; Wang, C.; Kikuchi, N.; Osada, R.; Nikaido, T.; Konishi, I., 2007:
BRCA1 Expression is an Important Biomarker for Chemosensitivity: Suppression of BRCA1 Increases the Apoptosis via Up-regulation of p53 and p21 During Cisplatin Treatment in Ovarian Cancer Cells

Krum, S.A.; la Rosa Dalugdugan, E.de.; Miranda-Carboni, G.A.; Lane, T.F., 2010:
BRCA1 Forms a Functional Complex with γ-H2AX as a Late Response to Genotoxic Stress

Saleh-Gohari, N.; Mohammadi-Anaie, M.; Kalantari-Khandani, B., 2012:
BRCA1 Gene Mutations in Breast Cancer Patients from Kerman Province, Iran

Madjd, Z.; Karimi, A.; Molanae, S.; Asadi-Lari, M., 2011:
BRCA1 Protein Expression Level and CD44(+)Phenotype in Breast Cancer Patients

Spurdle, A.B.; Whiley, P.J.; Thompson, B.; Feng, B.; Healey, S.; Brown, M.A.; Pettigrew, C.; Van Asperen, C.J.; Ausems, M.G.E.M.; Kattentidt-Mouravieva, A.A.; van den Ouweland, A.M.W.; Lindblom, A.; Pigg, M.H.; Schmutzler, R.K.; Engel, C.; Meindl, A.; Caputo, S.; Sinilnikova, O.M.; Lidereau, R.; Couch, F.J.; Guidugli, L.; Hansen, T.van.Overeem.; Thomassen, M.; Eccles, D.M.; Tucker, K.; Benitez, J.; Domchek, S.M.; Toland, A.E.; Van Rensburg, E.J.; Wappenschmidt, B.; Borg, Åke.; Vreeswijk, M.P.G., 2012:
BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk

Zhang, L.; Chen, L.; Bacares, R.; Ruggeri, J.M.; Somar, J.; Kemel, Y.; Stadler, Z.K.; Offit, K., 2012:
BRCA1 R71K missense mutation contributes to cancer predisposition by increasing alternative transcript levels

Drost, R.; Bouwman, P.; Rottenberg, S.; Boon, U.; Schut, E.; Klarenbeek, S.; Klijn, C.; van der Heijden, I.; van der Gulden, H.; Wientjens, E.; Pieterse, M.; Catteau, A.; Green, P.; Solomon, E.; Morris, J.R.; Jonkers, J., 2012:
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance

Cruz-García, Aés.; López-Saavedra, A.; Huertas, P., 2015:
BRCA1 accelerates CtIP-mediated DNA-end resection

Govatati, S.; Challa, K.; Reddy, S.B.; Pramod, K.; Deenadayal, M.; Chakravarty, B.; Shivaji, S.; Bhanoori, M., 2016:
BRCA1 alterations are associated with endometriosis, but BRCA2 alterations show no detectable endometriosis risk: a study in Indian population

Somasundaram, K., 2010:
BRCA1 and BRCA1 Genes and Inherited Breast and/or Ovarian Cancer: Benefits of Genetic Testing

Foulkes, W.D., 2014:
BRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective

Ginsburg, O.M.; Kim-Sing, C.; Foulkes, W.D.; Ghadirian, P.; Lynch, H.T.; Sun, P.; Narod, S.A.; Olopade, O.I.; Tung, N.; Couch, F.; Rosen, B.; Friedman, E.; Eisen, A.; Domchek, S.; Stoppa-Lyonnet, D.; Gershoni-Baruch, R.; Horsman, D.; Wagner, T.; Saal, H.; Meschino, W.; Offit, K.; Trivedi, A.; Robson, M.; Osborne, M.; Gilchrist, D.; Eng, C.; Weitzel, J.; McKinnon, W.; Wood, M.; Pasini, B.; Ainsworth, P.; Daly, M.; Garber, J.; Sweet, K.; Fallen, T.; Karlan, B.; Kurz, R.; Isaacs, C.; Neuhausen, S.;, 2011:
BRCA1 and BRCA2 families and the risk of skin cancer

Marchina, E.; Fontana, M.Grazia.; Speziani, M.; Salvi, A.; Ricca, G.; Di Lorenzo, D.; Gervasi, M.; Caimi, L.; Barlati, S., 2011:
BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management

Vogel, K.J.; Atchley, D.P.; Erlichman, J.; Broglio, K.R.; Ready, K.J.; Valero, V.; Amos, C.I.; Hortobagyi, G.N.; Lu, K.H.; Arun, B., 2007:
BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model

Vaidyanathan, K.; Lakhotia, S.; Ravishankar, H.M.; Tabassum, U.; Mukherjee, G.; Somasundaram, K., 2009:
BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation

Cherbal, F.; Bakour, R.; Adane, S.; Boualga, K., 2014:
BRCA1 and BRCA2 germline mutation spectrum in hereditary breast/ovarian cancer families from Maghrebian countries

Lucas, A.L.; Frado, L.E.; Hwang, C.; Kumar, S.; Khanna, L.G.; Levinson, E.J.; Chabot, J.A.; Chung, W.K.; Frucht, H., 2014:
BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts

Lim, M.Cheol.; Kang, S.; Seo, S-Soo.; Kong, S-Young.; Lee, B-Yon.; Lee, S-Kyung.; Park, S-Yoon., 2009:
BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients

Toh, G.Theng.; Kang, P.; Lee, S.S.W.; Lee, D.Shin-Chi.; Lee, S.Yee.; Selamat, S.; Mohd Taib, N.Aishah.; Yoon, S-Yee.; Yip, C.Har.; Teo, S-Hwang., 2008:
BRCA1 and BRCA2 germline mutations in Malaysian women with early-onset breast cancer without a family history

Tazzite, A.; Jouhadi, H.; Nadifi, S.; Aretini, P.; Falaschi, E.; Collavoli, A.; Benider, A.; Caligo, M.Adelaide., 2012:
BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants

Delgado, L.; Fernández, G.; Grotiuz, G.; Cataldi, S.; González, A.; Lluveras, N.; Heguaburu, M.; Fresco, R.; Lens, D.; Sabini, G.; Muse, I.M., 2011:
BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants

Cherbal, F.; Bakour, R.; Adane, S.; Boualga, K.; Benais-Pont, G.; Maillet, P., 2010:
BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families

Sioftanos, G.; Ismail, A.; Föhse, L.; Shanley, S.; Worku, M.; Short, S.C., 2011:
BRCA1 and BRCA2 heterozygosity in embryonic stem cells reduces radiation-induced Rad51 focus formation but is not associated with radiosensitivity

Narod, S.A., 2005:
BRCA1 and BRCA2 in 2005

Neuhausen, S.L.; Ozcelik, H.; Southey, M.C.; John, E.M.; Godwin, A.K.; Chung, W.; Iriondo-Perez, J.; Miron, A.; Santella, R.M.; Whittemore, A.; Andrulis, I.L.; Buys, S.S.; Daly, M.B.; Hopper, J.L.; Seminara, D.; Senie, R.T.; Terry, M.Beth., 2008:
BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research

Soegaard, M.; Kjaer, S.Kruger.; Cox, M.; Wozniak, E.; Høgdall, E.; Høgdall, C.; Blaakaer, J.; Jacobs, I.J.; Gayther, S.A.; Ramus, S.J., 2008:
BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark

Kurian, A.W., 2010:
BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications

Rodríguez, A.Ortiz.; Llacuachaqui, M.; Pardo, G.Guevara.; Royer, R.; Larson, G.; Weitzel, J.N.; Narod, S.A., 2012:
BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia

Narod, S.A.; Salmena, L., 2012:
BRCA1 and BRCA2 mutations and breast cancer

Smith, K.R.; Hanson, H.A.; Hollingshaus, M.S., 2013:
BRCA1 and BRCA2 mutations and female fertility

Sopik, V.; Phelan, C.; Cybulski, C.; Narod, S.A., 2016:
BRCA1 and BRCA2 mutations and the risk for colorectal cancer

Thomassen, M.; Hansen, T.V.O.; Borg, A.; Lianee, H.Theilmann.; Wikman, F.; Pedersen, I.Søkilde.; Bisgaard, M.Luise.; Nielsen, F.C.; Kruse, T.A.; Gerdes, A-Marie., 2008:
BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer

Lara, K.; Consigliere, N.; Pérez, J.; Porco, A., 2014:
BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela

Esteban Cardeñosa, E.; Bolufer Gilabert, P.; Palanca Suela, S.; Barragán González, E.; Oltra Soler, S.; Chirivella González, I.; Segura Huerta, A.; Guillén Ponce, C.; Martínez de Dueñas, E.; Cuevas Cuerda, D.; Salas Trejo, D., 2008:
BRCA1 and BRCA2 mutations in families studied in the program of genetic counselling in cancer of the Valencian community (Spain)

Swisher, E.; Walsh, T., 2012:
BRCA1 and BRCA2 mutations in ovarian cancer

Shanmughapriya, S.; Nachiappan, V.; Natarajaseenivasan, K., 2013:
BRCA1 and BRCA2 mutations in the ovarian cancer population across race and ethnicity: special reference to Asia

Hall, M.J.; Reid, J.E.; Burbidge, L.A.; Pruss, D.; Deffenbaugh, A.M.; Frye, C.; Wenstrup, R.J.; Ward, B.E.; Scholl, T.A.; Noll, W.W., 2009:
BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

Ratajska, M.; Brozek, I.; Senkus-Konefka, E.; Jassem, J.; Stepnowska, M.; Palomba, G.; Pisano, M.; Casula, M.; Palmieri, G.; Borg, A.; Limon, J., 2007:
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland

Kessler, L.; Domchek, S.; Stopfer, J.; Halbert, C.Hughes., 2008:
BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer

Cherbal, F.; Salhi, N.; Bakour, R.; Adane, S.; Boualga, K.; Maillet, P., 2012:
BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families

Miller-Samuel, S.; Rosenberg, A.; Berger, A.; Gomella, L.; Loren, D.; Morris, G.J., 2011:
BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management

O'Donovan, P.J.; Livingston, D.M., 2010:
BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair

Sedukhina, A.; Fukuda, T.; Ohta, T., 2012:
BRCA1 and DNA damage response

Stecklein, S.R.; Kumaraswamy, E.; Behbod, F.; Wang, W.; Chaguturu, V.; Harlan-Williams, L.M.; Jensen, R.A., 2012:
BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2/M checkpoint activation

Yi, Y.Weon.; Kang, H.Jin.; Bae, I., 2014:
BRCA1 and Oxidative Stress

Kranz, D.; Dohmesen, C.; Dobbelstein, M., 2008:
BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathways

Shim, H.Jeong.; Yun, J.Young.; Hwang, J.Eul.; Bae, W.Kyun.; Cho, S.Hee.; Lee, J.Hee.; Kim, H.Nam.; Shin, M.Ho.; Kweon, S.Seog.; Lee, J.Hyuk.; Kim, H.Joon.; Chung, I.Joo., 2010:
BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin

Wang, L.; Di, L-Jun., 2014:
BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?

Quinn, J.E.; Carser, J.E.; James, C.R.; Kennedy, R.D.; Harkin, D.Paul., 2009:
BRCA1 and implications for response to chemotherapy in ovarian cancer

Clark-Knowles, K.V.; O'Brien, A.M.; Weberpals, J.I., 2010:
BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer

Romagnolo, A.P.G.; Romagnolo, D.F.; Selmin, O.I., 2015:
BRCA1 as target for breast cancer prevention and therapy

Molyneux, G.; Geyer, F.C.; Magnay, F-Ann.; McCarthy, A.; Kendrick, H.; Natrajan, R.; Mackay, A.; Grigoriadis, A.; Tutt, A.; Ashworth, A.; Reis-Filho, J.S.; Smalley, M.J., 2010:
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells

Raskin, L.; Lejbkowicz, F.; Barnett-Griness, O.; Dishon, S.; Almog, R.; Rennert, G., 2009:
BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews

Brandão, R.D.; van Roozendaal, K.E.P.; Tserpelis, D.; Caanen, B.; Gómez García, E.; Blok, M.J., 2012:
BRCA1 c.4987-3C>G is a pathogenic mutation

Wei, L.; Lan, L.; Yasui, A.; Tanaka, K.; Saijo, M.; Matsuzawa, A.; Kashiwagi, R.; Maseki, E.; Hu, Y.; Parvin, J.D.; Ishioka, C.; Chiba, N., 2012:
BRCA1 contributes to transcription-coupled repair of DNA damage through polyubiquitination and degradation of Cockayne syndrome B protein

Heine, G.F.; Parvin, J.D., 2007:
BRCA1 control of steroid receptor ubiquitination

Savage, K.I.; Matchett, K.B.; Barros, E.M.; Cooper, K.M.; Irwin, G.W.; Gorski, J.J.; Orr, K.S.; Vohhodina, J.; Kavanagh, J.N.; Madden, A.F.; Powell, A.; Manti, L.; McDade, S.S.; Park, B.Ho.; Prise, K.M.; McIntosh, S.A.; Salto-Tellez, M.; Richard, D.J.; Elliott, C.T.; Harkin, D.Paul., 2014:
BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability

Sotiropoulou, P.A.; Karambelas, A.E.; Debaugnies, M.; Candi, A.; Bouwman, P.; Moers, V.; Revenco, T.; Rocha, A.Sofia.; Sekiguchi, K.; Jonkers, J.; Blanpain, C., 2013:
BRCA1 deficiency in skin epidermis leads to selective loss of hair follicle stem cells and their progeny

Tang, M.K.S.; Kwong, A.; Tam, K-Fai.; Cheung, A.N.Y.; Ngan, H.Y.S.; Xia, W.; Wong, A.S.T., 2014:
BRCA1 deficiency induces protective autophagy to mitigate stress and provides a mechanism for BRCA1 haploinsufficiency in tumorigenesis

Diaz-Cruz, E.S.; Cabrera, M.C.; Nakles, R.; Rutstein, B.H.; Furth, P.A., 2012:
BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer

Zou, J.; Rezvani, K.; Wang, H.; Lee, K.S.; Zhang, D., 2014:
BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress

Stefansson, O.A.; Villanueva, A.; Vidal, A.; Martí, L.; Esteller, M., 2013:
BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer

Broering, T.J.; Alavattam, K.G.; Sadreyev, R.I.; Ichijima, Y.; Kato, Y.; Hasegawa, K.; Camerini-Otero, R.Daniel.; Lee, J.T.; Andreassen, P.R.; Namekawa, S.H., 2014:
BRCA1 establishes DNA damage signaling and pericentric heterochromatin of the X chromosome in male meiosis

Raponi, M.; Smith, L.D.; Silipo, M.; Stuani, C.; Buratti, E.; Baralle, D., 2015:
BRCA1 exon 11 a model of long exon splicing regulation

Tammaro, C.; Raponi, M.; Wilson, D.I.; Baralle, D., 2012:
BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer

Mangia, A.; Chiriatti, A.; Tommasi, S.; Menolascina, F.; Petroni, S.; Zito, F.A.; Simone, G.; Schittulli, F.; Paradiso, A., 2008:
BRCA1 expression and molecular alterations in familial breast cancer

Comănescu, M.; Popescu, C.Florina., 2009:
BRCA1 expression in invasive breast carcinomas and clinicopathological correlations

Galizia, E.; Giorgetti, G.; Piccinini, G.; Santinelli, A.; Loretelli, C.; Bianchi, F.; Gagliardini, D.; Carbonari, G.; Pisa, E.; Belvederesi, L.; Bracci, R.; Ferretti, C.; Corradini, F.; Cellerino, R., 2010:
BRCA1 expression in triple negative sporadic breast cancers

May, T.; Yang, J.; Shoni, M.; Liu, S.; He, H.; Gali, R.; Ng, S-Kay.; Crum, C.; Berkowitz, R.S.; Ng, S-Wing., 2014:
BRCA1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein 2

Li, L., 2011:
BRCA1 forks over new roles in DNA-damage response- before and beyond the breaks

Savanevich, A.; Oszurek, O.; Lubiński, J.; Cybulski, C.; Dębniak, T.; Narod, S.A.; Gronwald, J., 2015:
BRCA1 founder mutations compared to ovarian cancer in Belarus

Bunting, S.F.; Callén, E.; Kozak, M.L.; Kim, J.Min.; Wong, N.; López-Contreras, Aés.J.; Ludwig, T.; Baer, R.; Faryabi, R.B.; Malhowski, A.; Chen, H-Tang.; Fernandez-Capetillo, O.; D'Andrea, A.; Nussenzweig, Aé., 2012:
BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair

Al-Moundhri, M.S.; Al-Ansari, A.; Al-Mawali, K.; Al-Bahrani, B., 2016:
BRCA1 gene Molecular Alterations in Omani Breast Cancer Patients

Cao, Y-Wen.; Fu, X-Ge.; Wan, G-Xing.; Yu, S-Ying.; Cui, X-Bin.; Li, L.; Jiang, J-Fang.; Zheng, Y-Qin.; Zhang, W-Jie.; Li, F., 2015:
BRCA1 gene exon 11 mutations in Uighur and Han women with early-onset sporadic breast cancer in the northwest region of China

Yi, E.Jue.; Park, J.Ho.; Lee, H.Won.; Cho, S.Youn.; Na, I.Il.; Kang, M.Chul., 2013:
BRCA1 gene mutation in thymic malignant melanoma

Einbeigi, Z.; Enerbäck, C.; Wallgren, A.; Nordling, M.; Karlsson, P., 2010:
BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region

Ruscito, I.; Dimitrova, D.; Vasconcelos, I.; Gellhaus, K.; Schwachula, T.; Bellati, F.; Zeillinger, R.; Benedetti-Panici, P.; Vergote, I.; Mahner, S.; Cacsire-Tong, D.; Concin, N.; Darb-Esfahani, S.; Lambrechts, S.; Sehouli, J.; Olek, S.; Braicu, E.I., 2014:
BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)

Tihomirova, L.; Vaivade, I.; Fokina, O.; Peculis, R.; Mandrika, I.; Sinicka, O.; Stengrevics, A.; Krilova, A.; Keire, G.; Petrevics, J.; Eglitis, J.; Timofejevs, M.; Leja, M., 2015:
BRCA1 gene-related hereditary susceptibility to breast and ovarian cancer in Latvia

Chen, W.; Pan, K.; Ouyang, T.; Li, J.; Wang, T.; Fan, Z.; Fan, T.; Lin, B.; Lu, Y.; You, W.; Xie, Y., 2008:
BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer

Wang, E.T.; Pisarska, M.D.; Bresee, C.; Chen, Y-Der.Ida.; Lester, J.; Afshar, Y.; Alexander, C.; Karlan, B.Y., 2015:
BRCA1 germline mutations may be associated with reduced ovarian reserve

Feilotter, H.E.; Michel, C.; Uy, P.; Bathurst, L.; Davey, S., 2015:
BRCA1 haploinsufficiency leads to altered expression of genes involved in cellular proliferation and development

Salmena, L.; Narod, S., 2012:
BRCA1 haploinsufficiency: consequences for breast cancer

Beirne, J.P.; Quinn, J.E.; Maxwell, P.; Kalloger, S.E.; McAlpine, J.; Gilks, C.Blake.; Harley, I.J.G.; McCluggage, W.Glenn., 2013:
BRCA1 immunohistochemical staining as a prognostic indicator in uterine serous carcinoma

Roehe, A.Vial.; Boff, A.Letícia.; Damin, Aéa., 2013:
BRCA1 immunohistochemistry assay: can it play a role in assessing sporadic early-onset breast cancer?

Garg, K.; Levine, D.A.; Olvera, N.; Dao, F.; Bisogna, M.; Secord, A.Alvarez.; Berchuck, A.; Cerami, E.; Schultz, N.; Soslow, R.A., 2013:
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas

Rosen, E.M., 2013:
BRCA1 in the DNA damage response and at telomeres

Privat, M.; Radosevic-Robin, N.; Aubel, C.; Cayre, A.; Penault-Llorca, Fédérique.; Marceau, G.; Sapin, V.; Bignon, Y-Jean.; Morvan, D., 2015:
BRCA1 induces major energetic metabolism reprogramming in breast cancer cells

Xiong, J.; Zhao, J.; Peng, L.; Wang, H.; Liang, W., 2013:
BRCA1 inhibits progesterone-induced proliferation and migration of breast cancer cells

Jin, S.; Gao, H.; Mazzacurati, L.; Wang, Y.; Fan, W.; Chen, Q.; Yu, W.; Wang, M.; Zhu, X.; Zhang, C.; Zhan, Q., 2009:
BRCA1 interaction of centrosomal protein Nlp is required for successful mitotic progression

Li, H.; Sekine, M.; Seng, S.; Avraham, S.; Avraham, H.Karsenty., 2010:
BRCA1 interacts with Smad3 and regulates Smad3-mediated TGF-beta signaling during oxidative stress responses

Kalb, R.; Mallery, D.L.; Larkin, C.; Huang, J.T.J.; Hiom, K., 2015:
BRCA1 is a histone-H2A-specific ubiquitin ligase

Buckley, N.E.; Nic An tSaoir, C.B.; Blayney, J.K.; Oram, L.C.; Crawford, N.T.; D'Costa, Z.C.; Quinn, J.E.; Kennedy, R.D.; Harkin, D.Paul.; Mullan, P.B., 2013:
BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers

Beuret, L.; Ohanna, M.; Strub, T.; Allegra, M.; Davidson, I.; Bertolotto, C.; Ballotti, R., 2011:
BRCA1 is a new MITF target gene

Jackson, K.C.; Gidlund, E-Karin.; Norrbom, J.; Valencia, A.P.; Thomson, D.M.; Schuh, R.A.; Neufer, P.Darrell.; Spangenburg, E.E., 2014:
BRCA1 is a novel regulator of metabolic function in skeletal muscle

Singh, K.K.; Shukla, P.C.; Quan, A.; Al-Omran, M.; Lovren, F.; Pan, Y.; Brezden-Masley, C.; Ingram, A.J.; Stanford, W.L.; Teoh, H.; Verma, S., 2013:
BRCA1 is a novel target to improve endothelial dysfunction and retard atherosclerosis

Carser, J.E.; Quinn, J.E.; Michie, C.O.; O'Brien, E.J.; McCluggage, W.Glenn.; Maxwell, P.; Lamers, E.; Lioe, T.F.; Williams, A.R.W.; Kennedy, R.D.; Gourley, C.; Harkin, D.Paul., 2011:
BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer

Amichay, K.; Kidron, D.; Attias-Geva, Z.; Schayek, H.; Sarfstein, R.; Fishman, A.; Werner, H.; Bruchim, I., 2012:
BRCA1 is expressed in uterine serous carcinoma (USC) and controls insulin-like growth factor I receptor (IGF-IR) gene expression in USC cell lines

Chabalier-Taste, C.; Racca, C.; Dozier, C.; Larminat, F., 2008:
BRCA1 is regulated by Chk2 in response to spindle damage

Xiong, B.; Li, S.; Ai, J-Shu.; Yin, S.; Ouyang, Y-Chun.; Sun, S-Chen.; Chen, D-Yuan.; Sun, Q-Yuan., 2008:
BRCA1 is required for meiotic spindle assembly and spindle assembly checkpoint activation in mouse oocytes

Cabuy, E.; Newton, C.; Slijepcevic, P., 2009:
BRCA1 knock-down causes telomere dysfunction in mammary epithelial cells

Ballal, R.D.; Saha, T.; Fan, S.; Haddad, B.R.; Rosen, E.M., 2010:
BRCA1 localization to the telomere and its loss from the telomere in response to DNA damage

Grotsky, D.A.; Gonzalez-Suarez, I.; Novell, A.; Neumann, M.A.; Yaddanapudi, S.C.; Croke, M.; Martinez-Alonso, M.; Redwood, A.B.; Ortega-Martinez, S.; Feng, Z.; Lerma, E.; Ramon y Cajal, T.; Zhang, J.; Matias-Guiu, X.; Dusso, A.; Gonzalo, S., 2013:
BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells

Bednarz, N.; Eltze, E.; Semjonow, A.; Rink, M.; Andreas, A.; Mulder, L.; Hannemann, J.; Fisch, M.; Pantel, K.; Weier, H-Ulrich.G.; Bielawski, K.P.; Brandt, B., 2010:
BRCA1 loss preexisting in small subpopulations of prostate cancer is associated with advanced disease and metastatic spread to lymph nodes and peripheral blood

Font, A.; Taron, M.; Gago, J.L.; Costa, C.; Sánchez, J.J.; Carrato, C.; Mora, M.; Celiz, P.; Perez, L.; Rodríguez, D.; Gimenez-Capitan, A.; Quiroga, V.; Benlloch, S.; Ibarz, L.; Rosell, R., 2011:
BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer

Gao, Y.; Zhu, J.; Zhang, X.; Wu, Q.; Jiang, S.; Liu, Y.; Hu, Z.; Liu, B.; Chen, X., 2013:
BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy

Quinn, J.E.; James, C.R.; Stewart, G.E.; Mulligan, J.M.; White, P.; Chang, G.K.F.; Mullan, P.B.; Johnston, P.G.; Wilson, R.H.; Harkin, D.Paul., 2007:
BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy

Evans, T.A.; Raina, A.K.; Delacourte, Aé.; Aprelikova, O.; Lee, H-gon.; Zhu, X.; Perry, G.; Smith, M.A., 2007:
BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease

Bol, G.Martinus.; van Diest, P.Joannes., 2011:
BRCA1 methylation and BRCA1 mutations in ovarian cancer

Promkan, M.; Liu, G.; Patmasiriwat, P.; Chakrabarty, S., 2009:
BRCA1 modulates malignant cell behavior, the expression of survivin and chemosensitivity in human breast cancer cells

Kang, H.Jin.; Kim, H.Jeong.; Kwon, S.Hoon.; Kang, B.Donghoon.; Eling, T.E.; Lee, S.Han.; Bae, I., 2007:
BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity

Davis, A.J.; Chi, L.; So, S.; Lee, K-Jong.; Mori, E.; Fattah, K.; Yang, J.; Chen, D.J., 2015:
BRCA1 modulates the autophosphorylation status of DNA-PKcs in S phase of the cell cycle

Santarosa, M.; Del Col, L.; Viel, A.; Bivi, N.; D'Ambrosio, C.; Scaloni, A.; Tell, G.; Maestro, R., 2011:
BRCA1 modulates the expression of hnRNPA2B1 and KHSRP

Tilanus-Linthorst, M.M.A.; Obdeijn, I-Marie.; Hop, W.C.J.; Causer, P.A.; Leach, M.O.; Warner, E.; Pointon, L.; Hill, K.; Klijn, J.G.M.; Warren, R.M.L.; Gilbert, F.J., 2007:
BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials

Suchy, J.; Cybulski, C.; Górski, B.; Huzarski, T.; Byrski, T.; Dębniak, T.; Gronwald, J.; Jakubowska, A.; Wokołorczyk, D.; Kurzawski, G.; Kładny, Józef.; Jawień, A.; Banaszkiewicz, Z.; Wiśniowski, Rł.; Wandzel, P.; Starzewski, J.; Lorenc, Z.; Korobowicz, Eżbieta.; Krokowicz, P.; Horbacka, K.; Lubiński, J.; Narod, S.A., 2011:
BRCA1 mutations and colorectal cancer in Poland

Cybulski, C.; Górski, B.; Gronwald, J.; Huzarski, T.; Byrski, T.; Debniak, T.; Jakubowska, A.; Wokołorczyk, D.; Gliniewicz, Błomiej.; Sikorski, A.; Stawicka, Młgorzata.; Godlewski, D.; Kwias, Z.; Antczak, A.; Krajka, K.; Lauer, W.; Sosnowski, M.; Sikorska-Radek, P.; Bar, K.; Klijer, R.; Romuald, Z.; Małkiewicz, B.; Borkowski, A.; Borkowski, T.; Szwiec, M.; Posmyk, M.; Narod, S.A.; Lubiński, J., 2007:
BRCA1 mutations and prostate cancer in Poland

Yasmeen, A.; Liu, W.; Dekhil, H.; Kassab, A.; Aloyz, R.; Foulkes, W.D.; Al Moustafa, A-Eddin., 2009:
BRCA1 mutations contribute to cell motility and invasion by affecting its main regulators

Fachal, L.; Gómez-Caamaño, A.; Celeiro-Muñoz, C.; Peleteiro, P.; Blanco, A.; Carballo, A.; Forteza, Jónimo.; Carracedo, A.; Vega, A., 2011:
BRCA1 mutations do not increase prostate cancer risk: results from a meta-analysis including new data

Martinez-Outschoorn, U.E.; Balliet, R.; Lin, Z.; Whitaker-Menezes, D.; Birbe, R.C.; Bombonati, A.; Pavlides, S.; Lamb, R.; Sneddon, S.; Howell, A.; Sotgia, F.; Lisanti, M.P., 2013:
BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies

Uhrhammer, N.; Abdelouahab, A.; Lafarge, L.; Feillel, V.; Ben Dib, A.; Bignon, Y-Jean., 2008:
BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases

Tamboom, K.; Kaasik, K.; Aršavskaja, J.; Tekkel, M.; Lilleorg, A.; Padrik, P.; Metspalu, A.; Veidebaum, T., 2010:
BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia

Esteve, J.M.; Armengod, Mía.Eugenia.; Knecht, E., 2010 :
BRCA1 negatively regulates formation of autophagic vacuoles in MCF-7 breast cancer cells

Yu, X.; Luo, Y.; Zhou, Y.; Zhang, Q.; Wang, J.; Wei, N.; Mi, M.; Zhu, J.; Wang, B.; Chang, H.; Tang, Y., 2008:
BRCA1 overexpression sensitizes cancer cells to lovastatin via regulation of cyclin D1-CDK4-p21WAF1/CIP1 pathway: analyses using a breast cancer cell line and tumoral xenograft model

Malacrida, S.; Agata, S.; Callegaro, M.; Casella, C.; Barana, D.; Scaini, M.C.; Manoukian, S.; Oliani, C.; Radice, P.; Barile, M.; Menin, C.; D'Andrea, E.; Montagna, M., 2008:
BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy

Hill, S.J.; Clark, A.P.; Silver, D.P.; Livingston, D.M., 2014:
BRCA1 pathway function in basal-like breast cancer cells

Biunno, I.; Aceto, G.; Awadelkarim, K.Dafaallah.; Morgano, A.; Elhaj, A.; Eltayeb, E.Abdalla.; Abuidris, D.Omer.; Elwali, N.Eldin.; Spinelli, C.; De Blasio, P.; Rovida, E.; Mariani-Costantini, R., 2015:
BRCA1 point mutations in premenopausal breast cancer patients from Central Sudan

Shilpa, V.; Bhagat, R.; Premalata, C.S.; Pallavi, V.R.; Ramesh, G.; Krishnamoorthy, L., 2014:
BRCA1 promoter hypermethylation and protein expression in ovarian carcinoma--an Indian study

Jacot, W.; Thezenas, S.; Senal, R.; Viglianti, C.; Laberenne, A-Claire.; Lopez-Crapez, E.; Bibeau, Fédéric.; Bleuse, J-Pierre.; Romieu, G.; Lamy, P-Jean., 2014:
BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer

Chen, Y.; Zhou, J.; Xu, Y.; Li, Z.; Wen, X.; Yao, L.; Xie, Y.; Deng, D., 2009:
BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer

Snell, C.; Krypuy, M.; Wong, E.Ming.; Loughrey, M.B.; Dobrovic, A., 2008:
BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype

Bosviel, Rémy.; Garcia, Séphane.; Lavediaux, G.; Michard, E.; Dravers, M.; Kwiatkowski, F.; Bignon, Y-Jean.; Bernard-Gallon, D.J., 2012:
BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls

Iwamoto, T.; Yamamoto, N.; Taguchi, T.; Tamaki, Y.; Noguchi, S., 2012:
BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation

Ignatov, T.; Poehlmann, A.; Ignatov, A.; Schinlauer, A.; Costa, S.D.; Roessner, A.; Kalinski, T.; Bischoff, J., 2014:
BRCA1 promoter methylation is a marker of better response to anthracycline-based therapy in sporadic TNBC

Ignatov, T.; Eggemann, H.; Costa, S.D.; Roessner, A.; Kalinski, T.; Ignatov, A., 2014:
BRCA1 promoter methylation is a marker of better response to platinum-taxane-based therapy in sporadic epithelial ovarian cancer

Xu, X.; Gammon, M.D.; Zhang, Y.; Bestor, T.H.; Zeisel, S.H.; Wetmur, J.G.; Wallenstein, S.; Bradshaw, P.T.; Garbowski, G.; Teitelbaum, S.L.; Neugut, A.I.; Santella, R.M.; Chen, J., 2008:
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer

Otani, Y.; Miyake, T.; Kagara, N.; Shimoda, M.; Naoi, Y.; Maruyama, N.; Shimomura, A.; Shimazu, K.; Kim, S.Jin.; Noguchi, S., 2014:
BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer

Cerne, J.Z.; Zong, L.; Jelinek, J.; Hilsenbeck, S.G.; Wang, T.; Oesterreich, S.; McGuire, S.E., 2013:
BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients

Tian, F.; Sharma, S.; Zou, J.; Lin, S-Yih.; Wang, B.; Rezvani, K.; Wang, H.; Parvin, J.D.; Ludwig, T.; Canman, C.E.; Zhang, D., 2013:
BRCA1 promotes the ubiquitination of PCNA and recruitment of translesion polymerases in response to replication blockade

Long, D.T.; Joukov, V.; Budzowska, M.; Walter, J.C., 2014:
BRCA1 promotes unloading of the CMG helicase from a stalled DNA replication fork

Tulchin, N.; Chambon, M.; Juan, G.; Dikman, S.; Strauchen, J.; Ornstein, L.; Billack, B.; Woods, N.T.; Monteiro, A.N.A., 2010:
BRCA1 protein and nucleolin colocalize in breast carcinoma tissue and cancer cell lines

Ashraf, M.; Jha, J.K.; Mukherjee, N.; Panda, C.K.; Nayak, S.; Jadhav, T.S.; Dikshit, N.; Nath, N.C.; Chakraborty, J.; Biswas, J., 2013:
BRCA1 protein expression and its correlation with ER/PR status in sporadic and familial breast cancer in Eastern Indian patients--a hospital based study

Hilton, J.; Weberpals, J.; Lorimer, I.; Amin, S.; Islam, S.; Pelletier, L.; Daneshmand, M.; Hanson, J.; Nabavi, M.; Parolin, D.; Mallick, R.; Verma, S., 2012:
BRCA1 protein levels and PIK3CA mutations as predictive biomarkers for response to neoadjuvant chemotherapy in locally advanced breast cancer: An exploratory analysis

Qin, Y.; Xu, J.; Aysola, K.; Oprea, G.; Reddy, A.; Matthews, R.; Okoli, J.; Cantor, A.; Grizzle, W.E.; Partridge, E.E.; Reddy, E.Shyam.P.; Landen, C.; Rao, V.N., 2012:
BRCA1 proteins regulate growth of ovarian cancer cells by tethering Ubc9

Buckley, N.E.; Hosey, A.M.; Gorski, J.J.; Purcell, J.W.; Mulligan, J.M.; Harkin, D.Paul.; Mullan, P.B., 2007:
BRCA1 regulates IFN-gamma signaling through a mechanism involving the type I IFNs

Ma, Y.; Fan, S.; Hu, C.; Meng, Q.; Fuqua, S.A.; Pestell, R.G.; Tomita, Y.A.; Rosen, E.M., 2010:
BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha

Karve, T.M.; Preet, A.; Sneed, R.; Salamanca, C.; Li, X.; Xu, J.; Kumar, D.; Rosen, E.M.; Saha, T., 2012:
BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells

Sankaran, S.; Crone, D.E.; Palazzo, R.E.; Parvin, J.D., 2007:
BRCA1 regulates gamma-tubulin binding to centrosomes

Liu, B.; Li, D.; Guan, Y-Fu., 2014:
BRCA1 regulates insulin-like growth factor 1 receptor levels in ovarian cancer

Guo, Y-xia.; Zeng, W-sen.; Liu, Y-wei.; Li, Y-sheng.; Lin, J.; Xiong, J-bo.; Luo, S-qiu., 2008:
BRCA1 regulates progesterone receptors A and B protein expressions in breast cancer cells in vitro

Saha, T.; Smulson, M.; Rosen, E.M., 2011:
BRCA1 regulation of base excision repair pathway

Lamber, E.P.; Horwitz, A.A.; Parvin, J.D., 2010:
BRCA1 represses amphiregulin gene expression

Hair, J.M.; Terzoudi, G.I.; Hatzi, V.I.; Lehockey, K.A.; Srivastava, D.; Wang, W.; Pantelias, G.E.; Georgakilas, A.G., 2010:
BRCA1 role in the mitigation of radiotoxicity and chromosomal instability through repair of clustered DNA lesions

Wang, X.; Zhao, T.; Zhao, J-jia.; Xiong, J-bo., 2010:
BRCA1 selectively regulates the expression of progesterone receptor A in sporadic invasive ductal breast carcinoma

Lovren, F.; Pan, Y.; Quan, A.; Singh, K.K.; Khan, R.; Gupta, N.; Brezden-Masley, C.; Teoh, H.; Wheatcroft, M.D.; Al-Omran, M.; Verma, S., 2014:
BRCA1 shields vascular smooth muscle cells from oxidative stress

Chen, P.; Hu, H.; Chen, Z.; Cai, X.; Zhang, Z.; Yang, Y.; Yu, N.; Zhang, J.; Xia, L.; Ge, J.; Yu, K.; Zhuang, J., 2015:
BRCA1 silencing is associated with failure of DNA repairing in retinal neurocytes

Moatter, T.; Aban, M.; Khan, S.; Azam, I.; Pervez, S., 2012:
BRCA1 status in Pakistani breast cancer patients with moderate family history

Bai, F.; Chan, H.Lam.; Scott, A.; Smith, M.D.; Fan, C.; Herschkowitz, J.I.; Perou, C.M.; Livingstone, A.S.; Robbins, D.J.; Capobianco, A.J.; Pei, X-Hai., 2015:
BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development

Promkan, M.; Liu, G.; Patmasiriwat, P.; Chakrabarty, S., 2011:
BRCA1 suppresses the expression of survivin and promotes sensitivity to paclitaxel through the calcium sensing receptor (CaSR) in human breast cancer cells

Górski, B.; Lubinski, J., 2008:
BRCA1 testing

Kang, H.Jin.; Kim, H.Jeong.; Cho, C-Heum.; Hu, Y.; Li, R.; Bae, I., 2008:
BRCA1 transcriptional activity is enhanced by interactions between its AD1 domain and AhR

Gorski, J.J.; James, C.R.; Quinn, J.E.; Stewart, G.E.; Staunton, K.Crosbie.; Buckley, N.E.; McDyer, F.A.; Kennedy, R.D.; Wilson, R.H.; Mullan, P.B.; Harkin, D.Paul., 2010:
BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer

Evans, D.Gareth.; Ahmed, M.; Bayliss, S.; Howard, E.; Lalloo, F.; Wallace, A., 2010:
BRCA1, BRCA2 and CHEK2 c.1100 delC mutations in patients with double primaries of the breasts and/or ovaries

Rabiau, Nège.; Déchelotte, P.; Adjakly, M.; Kemeny, J-Louis.; Guy, L.; Boiteux, J-Paul.; Kwiatkowski, F.; Bignon, Y-Jean.; Bernard-Gallon, D., 2011:
BRCA1, BRCA2, AR and IGF-I expression in prostate cancer: correlation between RT-qPCR and immunohistochemical detection

Monnerat, C.; Chompret, Aès.; Kannengiesser, C.; Avril, M-Françoise.; Janin, N.; Spatz, A.; Guinebretière, J-Marc.; Marian, C.; Barrois, M.; Boitier, Fçoise.; Lenoir, G.M.; Bressac-de Paillerets, B., 2007:
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma

Burdak-Rothkamm, S.; Rothkamm, K.; McClelland, K.; Al Rashid, S.T.; Prise, K.M., 2015:
BRCA1, FANCD2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells

Karachaliou, N.; Costa, C.; Gimenez-Capitan, A.; Molina-Vila, M.Angel.; Bertran-Alamillo, J.; Mayo, C.; Massuti, B.; Majem, M.; Carcereny, E.; Moran, T.; Sanchez, J.Javier.; Viteri, S.; Gasco, A.; Wannesson, L.; Souglakos, J.; Jimeno, J.; Rosell, R., 2013:
BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutations

Aly, A.; Ganesan, S., 2011:
BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability

Savage, K.I.; Harkin, D.Paul., 2015:
BRCA1, a 'complex' protein involved in the maintenance of genomic stability

Hu, Y., 2009:
BRCA1, hormone, and tissue-specific tumor suppression

Almeida, M.Inês.; Reis, R.M.; Calin, G.A., 2011:
BRCA1, microRNAs and cancer predisposition: challenging the dogma

Pristauz, G.; Geigl, J.B.; Petru, E., 2010:
BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer

Ahrens, P.; Kreipe, H.H., 2010:
BRCA1- and BRCA2- associated breast carcinomas

Pothuri, B., 2014 :
BRCA1- and BRCA2-related mutations: therapeutic implications in ovarian cancer

Buckley, N.E.; Mullan, P.B., 2012:
BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer

Dacheux, E.; Vincent, A.; Nazaret, N.; Combet, C.; Wierinckx, A.; Mazoyer, S.; Diaz, J-Jacques.; Lachuer, Jël.; Venezia, N.Dalla., 2013:
BRCA1-Dependent Translational Regulation in Breast Cancer Cells

Chock, K.L.; Allison, J.M.S.; Shimizu, Y.; ElShamy, W.M., 2010:
BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells

Shimizu, Y.; Luk, H.; Horio, D.; Miron, P.; Griswold, M.; Iglehart, D.; Hernandez, B.; Killeen, J.; ElShamy, W.M., 2012:
BRCA1-IRIS overexpression promotes formation of aggressive breast cancers

Jiang, G.; Plo, I.; Wang, T.; Rahman, M.; Cho, J.Hwan.; Yang, E.; Lopez, B.S.; Xia, F., 2013:
BRCA1-Ku80 protein interaction enhances end-joining fidelity of chromosomal double-strand breaks in the G1 phase of the cell cycle

Jakubowska, A.; Gronwald, J.; Menkiszak, J.; Górski, B.; Huzarski, T.; Byrski, T.; Tołoczko-Grabarek, A.; Gilbert, M.; Edler, L.; Zapatka, M.; Eils, R.; Lubiński, J.; Scott, R.J.; Hamann, U., 2010:
BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms

Rijnsburger, A.J.; Obdeijn, I-Marie.; Kaas, R.; Tilanus-Linthorst, M.M.A.; Boetes, C.; Loo, C.E.; Wasser, M.N.J.M.; Bergers, E.; Kok, T.; Muller, S.H.; Peterse, H.; Tollenaar, R.A.E.M.; Hoogerbrugge, N.; Meijer, S.; Bartels, C.C.M.; Seynaeve, C.; Hooning, M.J.; Kriege, M.; Schmitz, P.I.M.; Oosterwijk, J.C.; de Koning, H.J.; Rutgers, E.J.T.; Klijn, J.G.M., 2011:
BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

Ibrahim, N.; He, L.; Leong, C-Onn.; Xing, D.; Karlan, B.Y.; Swisher, E.M.; Rueda, B.R.; Orsulic, S.; Ellisen, L.W., 2010:
BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma

Chapman, J.Ross.; Sossick, A.J.; Boulton, S.J.; Jackson, S.P., 2013:
BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair

Nishikawa, H.; Wu, W.; Koike, A.; Kojima, R.; Gomi, H.; Fukuda, M.; Ohta, T., 2009:
BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity

Ventii, K.H.; Devi, N.S.; Friedrich, K.L.; Chernova, T.A.; Tighiouart, M.; Van Meir, E.G.; Wilkinson, K.D., 2008:
BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization

Puppe, J.; Drost, R.; Liu, X.; Joosse, S.A.; Evers, B.; Cornelissen-Steijger, P.; Nederlof, P.; Yu, Q.; Jonkers, J.; van Lohuizen, M.; Pietersen, A.M., 2010:
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A

Yarden, R.I.; Metsuyanim, S.; Pickholtz, I.; Shabbeer, S.; Tellio, H.; Papa, M.Z., 2013:
BRCA1-dependent Chk1 phosphorylation triggers partial chromatin disassociation of phosphorylated Chk1 and facilitates S-phase cell cycle arrest

Dever, S.M.; White, E.Railey.; Hartman, M.C.T.; Valerie, K., 2012:
BRCA1-directed, enhanced and aberrant homologous recombination: mechanism and potential treatment strategies

Dubeau, L., 2008:
BRCA1-induced ovarian oncogenesis

Kouznetsova, A.; Wang, H.; Bellani, M.; Camerini-Otero, R.Daniel.; Jessberger, R.; Höög, C., 2009:
BRCA1-mediated chromatin silencing is limited to oocytes with a small number of asynapsed chromosomes

Diao, H.; Wang, L.; Huang, J.; Jiang, M.; Zhou, H.; Li, X.; Chen, Q.; Jiang, Z.; Feng, H., 2014:
BRCA1-mediated inflammation and growth activated & inhibited transition mechanisms between no-tumor hepatitis/cirrhotic tissues and HCC

Dohrn, L.; Salles, D.; Siehler, S.Y.; Kaufmann, J.; Wiesmüller, L., 2012:
BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1

Shinagawa, H.; Miki, Y.; Yoshida, K., 2007:
BRCA1-mediated ubiquitination inhibits topoisomerase II alpha activity in response to oxidative stress

Holstege, H.; Horlings, H.M.; Velds, A.; Langerød, A.; Børresen-Dale, A-Lise.; van de Vijver, M.J.; Nederlof, P.M.; Jonkers, J., 2011:
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

Lisowska, K.Marta.; Dudaladava, V.; Jarzab, M.; Huzarski, T.; Chmielik, E.; Stobiecka, E.; Lubinski, J.; Jarzab, B., 2011:
BRCA1-related gene signature in breast cancer: the role of ER status and molecular type

Sambiasi, D.; Lambo, R.; Pilato, B.; Tommasi, S.; Trojano, G.; Kardhashi, A.; Digennaro, M.; Trojano, V.; Simone, G.; Paradiso, A., 2014:
BRCA1/2 and clinical outcome in a monoinstitutional cohort of women with hereditary breast cancer

Hu, Z.; Li, W-Feng.; Liu, X-Yi.; Zhang, B.; Cao, M-Zhi.; Wang, Y-Sheng.; Zhao, L.; Song, C-Gui.; Lu, J-Song.; Wu, J.; DI, G-Hong.; Shen, K-Wei.; Han, Q-Xia.; Shen, Z-Zhou.; Huang, W.; Shao, Z-Min., 2009:
BRCA1/2 gene mutation in Chinese familial breast cancer patients: a multi-center report of 115 cases

Tagliaferri, P.; Ventura, M.; Baudi, F.; Cucinotto, I.; Arbitrio, M.; Di Martino, M.Teresa.; Tassone, P., 2009:
BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality?

Goodman, A., 2012:
BRCA1/2 genetic testing found cost-effective in current era

Graves, K.D.; Gatammah, R.; Peshkin, B.N.; Krieger, A.; Gell, C.; Valdimarsdottir, H.B.; Schwartz, M.D., 2011:
BRCA1/2 genetic testing uptake and psychosocial outcomes in men

Cecener, G.; Egeli, U.; Tunca, B.; Erturk, E.; Ak, S.; Gokgoz, S.; Tasdelen, I.; Tezcan, G.; Demirdogen, E.; Bayram, N.; Avci, N.; Evrensel, T., 2015:
BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients

Bruchim, I.; Amichay, K.; Kidron, D.; Attias, Z.; Biron-Shental, T.; Drucker, L.; Friedman, E.; Werner, H.; Fishman, A., 2011:
BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma

Pal, T.; Vadaparampil, S.; Betts, J.; Miree, C.; Li, S.; Narod, S.A., 2008:
BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies

Evans, D.G.R.; Bulman, M.; Young, K.; Howard, E.; Bayliss, S.; Wallace, A.; Lalloo, F., 2007:
BRCA1/2 mutation analysis in male breast cancer families from North West England

Arts-de Jong, M.; Maas, A.H.E.M.; Massuger, L.F.; Hoogerbrugge, N.; de Hullu, J.A., 2015:
BRCA1/2 mutation carriers are potentially at higher cardiovascular risk

Rudaitis, V.; Zvirblis, T.; Kanopiene, D.; Janulynaite, D.; Griskevicius, L.; Janavicius, R., 2015:
BRCA1/2 mutation status is an independent factor of improved survival for advanced (stage III-IV) ovarian cancer

Dann, R.Byler.; DeLoia, J.A.; Timms, K.M.; Zorn, K.K.; Potter, J.; Flake, D.D.; Lanchbury, J.S.; Krivak, T.C., 2012:
BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer

Peshkin, B.N.; Alabek, M.L.; Isaacs, C., 2012:
BRCA1/2 mutations and triple negative breast cancers

Weghofer, A.; Tea, M-Kheng.; Barad, D.H.; Kim, A.; Singer, C.F.; Wagner, K.; Gleicher, N., 2013:
BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?

da Silva, J., 2012:
BRCA1/2 mutations, fertility and the grandmother effect

Patankar, J.V., 2014:
BRCA1/2 negative status predicts no extended risk of invasive ovarian cancer

Denayer, L.; Boogaerts, A.; Philippe, K.; Legius, E.; Evers-Kiebooms, G., 2010:
BRCA1/2 predictive testing and gender: uptake, motivation and psychological characteristics

Lindor, N.M.; Goldgar, D.E.; Tavtigian, S.V.; Plon, S.E.; Couch, F.J., 2014:
BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management

Cvelbar, M.; Hocevar, M.; Vidmar, G.; Teugels, E., 2011:
BRCA1/2 status and clinicopathologic characteristics of patients with double primary breast and ovarian cancer

O'Neill, S.C.; Valdimarsdottir, H.B.; Demarco, T.A.; Peshkin, B.N.; Graves, K.D.; Brown, K.; Hurley, K.E.; Isaacs, C.; Hecker, S.; Schwartz, M.D., 2011:
BRCA1/2 test results impact risk management attitudes, intentions, and uptake

Garber, J.E., 2009:
BRCA1/2-associated and sporadic breast cancers: fellow travelers or not?

Thakar, A.; Parvin, J..D.; Zlatanova, J., 2010:
BRCA1/BARD1 E3 ubiquitin ligase can modify histones H2A and H2B in the nucleosome particle

Lu, Y.; Kang, T.; Hu, Y., 2011:
BRCA1/BARD1 complex interacts with steroidogenic factor 1--A potential mechanism for regulation of aromatase expression by BRCA1

Ottini, L.; Rizzolo, P.; Zanna, I.; Falchetti, M.; Masala, G.; Ceccarelli, K.; Vezzosi, V.; Gulino, A.; Giannini, G.; Bianchi, S.; Sera, F.; Palli, D., 2008:
BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy

Falchetti, M.; Lupi, R.; Rizzolo, P.; Ceccarelli, K.; Zanna, I.; Calò, V.; Tommasi, S.; Masala, G.; Paradiso, A.; Gulino, A.; Giannini, G.; Russo, A.; Palli, D.; Ottini, L., 2007:
BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases

Shimizu, Y.; Mullins, N.; Blanchard, Z.; Elshamy, W.M., 2012:
BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells

D'Andrea, A.D., 2013:
BRCA1: a missing link in the Fanconi anemia/BRCA pathway

Reguart, Ní.; Cardona, Aés.Felipe.; Carrasco, E.; Gomez, P.; Taron, M.; Rosell, R., 2009:
BRCA1: a new genomic marker for non-small-cell lung cancer

Li, M.; Fan, S., 2015:
BRCA1: a new predictive genomic marker for chemotherapy and radiotherapy of non-small cell lung cancer

Rosell, R.; Skrzypski, M.; Jassem, E.; Taron, M.; Bartolucci, R.; Sanchez, J.Javier.; Mendez, P.; Chaib, I.; Perez-Roca, L.; Szymanowska, A.; Rzyman, W.; Puma, F.; Kobierska-Gulida, G.; Farabi, R.; Jassem, J., 2007:
BRCA1: a novel prognostic factor in resected non-small-cell lung cancer

Jin, K.; Sukumar, S., 2011:
BRCA1: linking HOX to breast cancer suppression

Qiu, L-Xin.; Yao, L.; Xue, K.; Zhang, J.; Mao, C.; Chen, B.; Zhan, P.; Yuan, H.; Hu, X-Chun., 2010:
BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects

Zhao, W-Ting.; Wang, Y-Tian.; Huang, Z-Wei.; Fang, J., 2013:
BRCA2 affects the efficiency of DNA double-strand break repair in response to N-nitroso compounds with differing carcinogenic potentials

Goodheart, M.J.; Rose, S.L.; Hattermann-Zogg, M.; Smith, B.J.; De Young, B.R.; Buller, R.E., 2009:
BRCA2 alteration is important in clear cell carcinoma of the ovary

Jones, R.M.; Kotsantis, P.; Stewart, G.S.; Groth, P.; Petermann, E., 2015:
BRCA2 and RAD51 promote double-strand break formation and cell death in response to gemcitabine

Shive, H.R.; West, R.R.; Embree, L.J.; Golden, C.D.; Hickstein, D.D., 2014:
BRCA2 and TP53 collaborate in tumorigenesis in zebrafish

Wang, H-Feng.; Takenaka, K.; Nakanishi, A.; Miki, Y., 2011:
BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2

Yata, K.; Bleuyard, J-Yves.; Nakato, R.; Ralf, C.; Katou, Y.; Schwab, R.A.; Niedzwiedz, W.; Shirahige, K.; Esashi, F., 2015:
BRCA2 coordinates the activities of cell-cycle kinases to promote genome stability

Anczuków, O.; Buisson, M.; Léoné, Mélanie.; Coutanson, C.; Lasset, C.; Calender, A.; Sinilnikova, O.M.; Mazoyer, S., 2013:
BRCA2 deep intronic mutation causing activation of a cryptic exon: opening toward a new preventive therapeutic strategy

Garre, P.; Martín, L.; Sanz, J.; Romero, A.; Tosar, A.; Bando, I.; Llovet, P.; Diaque, P.; García-Paredes, B.; Díaz-Rubio, E.; de la Hoya, M.; Caldés, T., 2016:
BRCA2 gene: a candidate for clinical testing in familial colorectal cancer type X

Jonsdottir, A.Björk.; Vreeswijk, M.P.G.; Wolterbeek, R.; Devilee, P.; Tanke, H.J.; Eyfjörd, J.E.; Szuhai, K., 2009:
BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts

Rytelewski, M.; Tong, J.G.; Buensuceso, A.; Leong, H.S.; Maleki Vareki, S.; Figueredo, R.; Di Cresce, C.; Wu, S.Y.; Herbrich, S.M.; Baggerly, K.A.; Romanow, L.; Shepherd, T.; Deroo, B.J.; Sood, A.K.; Chambers, A.F.; Vincent, M.; Ferguson, P.J.; Koropatnick, J., 2015:
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis

Niwa, T.; Saito, H.; Imajoh-ohmi, S.; Kaminishi, M.; Seto, Y.; Miki, Y.; Nakanishi, A., 2009:
BRCA2 interacts with the cytoskeletal linker protein plectin to form a complex controlling centrosome localization

Jensen, R.B.; Ozes, A.; Kim, T.; Estep, A.; Kowalczykowski, S.C., 2013:
BRCA2 is epistatic to the RAD51 paralogs in response to DNA damage

Anonymous, 2015:
BRCA2 mutation linked to lung cancer risk

Azzouzi, A-Rahene.; Stoppa-Lyonnet, D.; Roupret, M.; Larre, Séphane.; Mangin, P.; Cussenot, O., 2007:
BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families

Meyer, P.; Landgraf, K.; Högel, B.; Eiermann, W.; Ataseven, B., 2012:
BRCA2 mutations and triple-negative breast cancer

Takaoka, M.; Saito, H.; Takenaka, K.; Miki, Y.; Nakanishi, A., 2014:
BRCA2 phosphorylated by PLK1 moves to the midbody to regulate cytokinesis mediated by nonmuscle myosin IIC

Bosviel, Rémy.; Durif, J.; Guo, J.; Mebrek, M.; Kwiatkowski, F.; Bignon, Y-Jean.; Bernard-Gallon, D.J., 2013:
BRCA2 promoter hypermethylation in sporadic breast cancer

Liu, L.; Fang, Y.; Fan, J.; Hu, J.; Xu, X.; Jin, X.; Wang, X.; Deng, M.; Wang, J.; Liu, W., 2015:
BRCA2 promoter polymorphism is associated with breast cancer prognosis in Chinese women

Singh, K.K.; Shukla, P.C.; Quan, A.; Desjardins, J-François.; Lovren, F.; Pan, Y.; Garg, V.; Gosal, S.; Garg, A.; Szmitko, P.E.; Schneider, M.D.; Parker, T.G.; Stanford, W.L.; Leong-Poi, H.; Teoh, H.; Al-Omran, M.; Verma, S., 2012:
BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure

Díez, O.; Gutiérrez-Enríquez, S., 2009:
BRCA2 splice site mutations in an Italian breast/ovarian cancer family

Zbuk, K.; Xie, C.; Young, R.; Heydarpour, M.; Pare, G.; Davis, A.Darlene.; Miller, R.; Lanktree, M.B.; Saleheen, D.; Danesh, J.; Yusuf, S.; Engert, J.C.; Hegele, R.A.; Anand, S.S., 2012:
BRCA2 variants and cardiovascular disease in a multi-ethnic study

Schmidt, C., 2010:
BRCA2, purified, reveals some of its secrets

Ying, S.; Myers, K.; Bottomley, S.; Helleday, T.; Bryant, H.E., 2009:
BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells

Carreira, A.; Kowalczykowski, S.C., 2010:
BRCA2: Shining light on the regulation of DNA-binding selectivity by RAD51

Evans, D.G.; Wu, C.L.; Birch, J.M., 2008:
BRCA2: a cause of Li-Fraumeni-like syndrome

Jensen, R.B., 2014:
BRCA2: one small step for DNA repair, one giant protein purified

Li, C.; Ji, Y.; Wang, C.; Liang, S.; Pan, F.; Zhang, C.; Chen, F.; Fu, H.; Wang, K.; Cui, D., 2014:
BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer

Wysham, W.Z.; Mhawech-Fauceglia, P.; Li, H.; Hays, L.; Syriac, S.; Skrepnik, T.; Wright, J.; Pande, N.; Hoatlin, M.; Pejovic, T., 2012:
BRCAness profile of sporadic ovarian cancer predicts disease recurrence

De Summa, S.; Pinto, R.; Sambiasi, D.; Petriella, D.; Paradiso, V.; Paradiso, A.; Tommasi, S., 2014:
BRCAness: a deeper insight into basal-like breast tumors

Block-Schmidt, A.S.; Dukowic-Schulze, S.; Wanieck, K.; Reidt, W.; Puchta, H., 2011:
BRCC36A is epistatic to BRCA1 in DNA crosslink repair and homologous recombination in Arabidopsis thaliana

Sofueva, S.; Du, L-Lin.; Limbo, O.; Williams, J.S.; Russell, P., 2010:
BRCT domain interactions with phospho-histone H2A target Crb2 to chromatin at double-strand breaks and maintain the DNA damage checkpoint

Gerloff, D.L.; Woods, N.T.; Farago, A.A.; Monteiro, A.N.A., 2012:
BRCT domains: A little more than kin, and less than kind

Leung, C.Chung.Yun.; Glover, J.N.Mark., 2011:
BRCT domains: easy as one, two, three

Stern, D.F., 2009:
BRCTing up is hard to do

Miles, D.G.; Rogers, K.C., 2015:
BRD control: tying it all together to deliver value to the industry

Hilton, W.Mark., 2015:
BRD in 2014: where have we been, where are we now, and where do we want to go?

McVey, D.Scott., 2010:
BRD research needs in the next 10-20 years

Layouni, S.; Buresi, C.; Thomas, P.; Malafosse, A.; Dogui, M., 2010:
BRD2 and TAP-1 genes and juvenile myoclonic epilepsy

Stewart, H.Jayne.Susan.; Horne, G.Abigail.; Bastow, S.; Chevassut, T.James.Telfer., 2014:
BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1

Devaiah, B.N.; Lewis, B.A.; Cherman, N.; Hewitt, M.C.; Albrecht, B.K.; Robey, P.G.; Ozato, K.; Sims, R.J.; Singer, D.S., 2012:
BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain

Voigt, P.; Reinberg, D., 2012:
BRD4 jump-starts transcription after mitotic silencing

Alsarraj, J.; Faraji, F.; Geiger, T.R.; Mattaini, K.R.; Williams, M.; Wu, J.; Ha, N-Han.; Merlino, T.; Walker, R.C.; Bosley, A.D.; Xiao, Z.; Andresson, T.; Esposito, D.; Smithers, N.; Lugo, D.; Prinjha, R.; Day, A.; Crawford, N.P.S.; Ozato, K.; Gardner, K.; Hunter, K.W., 2014:
BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane

Segura, M.F.; Fontanals-Cirera, Bárbara.; Gaziel-Sovran, A.; Guijarro, Mía.V.; Hanniford, D.; Zhang, G.; González-Gomez, P.; Morante, M.; Jubierre, L.; Zhang, W.; Darvishian, F.; Ohlmeyer, M.; Osman, I.; Zhou, M-Ming.; Hernando, E., 2014:
BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy

Nelson, B.A.; Lee, E.Y.; French, C.A.; Bauer, D.E.; Vargas, S.O., 2010:
BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findings

Valent, P.; Zuber, J., 2015:
BRD4: a BET(ter) target for the treatment of AML?

Park, S.Won.; Herrema, H.; Salazar, M.; Cakir, I.; Cabi, S.; Basibuyuk Sahin, F.; Chiu, Y-Hsin.; Cantley, L.C.; Ozcan, U., 2015:
BRD7 regulates XBP1s' activity and glucose homeostasis through its interaction with the regulatory subunits of PI3K

Kaeser, M.D.; Aslanian, A.; Dong, M-Qiu.; Yates, J.R.; Emerson, B.M., 2008:
BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells

Harte, M.T.; O'Brien, G.J.; Ryan, N.M.; Gorski, J.J.; Savage, K.I.; Crawford, N.T.; Mullan, P.B.; Harkin, D.Paul., 2010:
BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription

Chiu, Y-Hsin.; Lee, J.Y.; Cantley, L.C., 2014:
BRD7, a tumor suppressor, interacts with p85α and regulates PI3K activity

Yamada, H.Y.; Rao, C.V., 2009:
BRD8 is a potential chemosensitizing target for spindle poisons in colorectal cancer therapy

Wang, L.; Yang, R.; Davis, J.E., 2007:
BRDF invariant stereo using light transport constancy

Nozka, L.; Pech, M.; Hiklova, H.; Mandat, D.; Hrabovsky, M.; Schovanek, P.; Palatka, M., 2011:
BRDF profile of Tyvek and its implementation in the Geant4 simulation toolkit

Barda, S.; Yogev, L.; Paz, G.; Yavetz, H.; Lehavi, O.; Hauser, R.; Doniger, T.; Breitbart, H.; Kleiman, S.E., 2015:
BRDT gene sequence in human testicular pathologies and the implication of its single nucleotide polymorphism (rs3088232) on fertility

Chui, Y-Loon.; Ching, A.Ka-Keung.; Chen, S.; Yip, F-Ping.; Rowlands, D.Kenneth.; James, A.Edward.; Lee, K.Ka-Ho.; Chan, J.Yuek-Hon., 2010:
BRE over-expression promotes growth of hepatocellular carcinoma

Crawford, M.A.; Rivers, J.P., 1978:
BREAST FEEDING and DISASTER RELIEF

Grell, P.; Hejduk, K.; Vyzula, R., 2012:
BREAST registry

Anonymous, 2014:
BREATH without movement; a method for securing absolute rest for the lungs

Du Plessis, D., 2013:
BREATHE: a mirror on an under-recognised medical condition

Salyers, M.P.; Hudson, C.; Morse, G.; Rollins, A.L.; Monroe-DeVita, M.; Wilson, C.; Freeland, L., 2011:
BREATHE: a pilot study of a one-day retreat to reduce burnout among mental health professionals

Sherman, K.A.; Harcourt, D.M.; Lam, T.C.; Shaw, L-Kate.; Boyages, J., 2015:
BRECONDA: development and acceptability of an interactive decisional support tool for women considering breast reconstruction

Marinelli, L.J.; Piuri, M.; Swigonová, Z.; Balachandran, A.; Oldfield, L.M.; van Kessel, J.C.; Hatfull, G.F., 2009:
BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes

Anonymous, 2014 :
BREEDING of yeast

Schomburg, I.; Chang, A.; Placzek, S.; Söhngen, C.; Rother, M.; Lang, M.; Munaretto, C.; Ulas, S.; Stelzer, M.; Grote, A.; Scheer, M.; Schomburg, D., 2013:
BRENDA in 2013: integrated reactions, kinetic data, enzyme function data, improved disease classification: new options and contents in BRENDA

Chang, A.; Schomburg, I.; Placzek, S.; Jeske, L.; Ulbrich, M.; Xiao, M.; Sensen, C.W.; Schomburg, D., 2015:
BRENDA in 2015: exciting developments in its 25th year of existence

Chang, A.; Scheer, M.; Grote, A.; Schomburg, I.; Schomburg, D., 2009:
BRENDA, AMENDA and FRENDA the enzyme information system: new content and tools in 2009

Scheer, M.; Grote, A.; Chang, A.; Schomburg, I.; Munaretto, C.; Rother, M.; Söhngen, C.; Stelzer, M.; Thiele, J.; Schomburg, D., 2011:
BRENDA, the enzyme information system in 2011

Siddiqui, S.; Cong, W-Na.; Daimon, C.M.; Martin, B.; Maudsley, S., 2013:
BRET Biosensor Analysis of Receptor Tyrosine Kinase Functionality

Cottet, M.; Faklaris, O.; Maurel, D.; Scholler, P.; Doumazane, E.; Trinquet, E.; Pin, J-Philippe.; Durroux, T., 2012:
BRET and Time-resolved FRET strategy to study GPCR oligomerization: from cell lines toward native tissues

Espinoza, S.; Masri, B.; Salahpour, A.; Gainetdinov, R.R., 2013:
BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling

Salahpour, A.; Espinoza, S.; Masri, B.; Lam, V.; Barak, L.S.; Gainetdinov, R.R., 2012:
BRET biosensors to study GPCR biology, pharmacology, and signal transduction

Borghei, G.; Hall, E.A.H., 2015:
BRET-linked ATP assay with luciferase

De, A.; Ray, P.; Loening, A.Markus.; Gambhir, S.Sam., 2009:
BRET3: a red-shifted bioluminescence resonance energy transfer (BRET)-based integrated platform for imaging protein-protein interactions from single live cells and living animals

Reveal, B.; Yan, N.; Snee, M.J.; Pai, C-I.; Gim, Y.; Macdonald, P.M., 2010:
BREs mediate both repression and activation of oskar mRNA translation and act in trans

Singhal, N.; Esch, D.; Stehling, M.; Schöler, H.R., 2014:
BRG1 Is Required to Maintain Pluripotency of Murine Embryonic Stem Cells

Sena, J.A.; Wang, L.; Hu, C-Jun., 2013:
BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes

Rodriguez-Nieto, S.; Sanchez-Cespedes, M., 2009:
BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer

Cleary, I.A.; Lazzell, A.L.; Monteagudo, C.; Thomas, D.P.; Saville, S.P., 2012:
BRG1 and NRG1 form a novel feedback circuit regulating Candida albicans hypha formation and virulence

Cohen, S.M.; Chastain, P.D.; Rosson, G.B.; Groh, B.S.; Weissman, B.E.; Kaufman, D.G.; Bultman, S.J., 2011:
BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression

Kim, S-Il.; Bresnick, E.H.; Bultman, S.J., 2009:
BRG1 directly regulates nucleosome structure and chromatin looping of the alpha globin locus to activate transcription

Lin, H.; Wong, R.P.C.; Martinka, M.; Li, G., 2011:
BRG1 expression is increased in human cutaneous melanoma

Wang, S.; Zhang, X.; Yuan, Y.; Tan, M.; Zhang, L.; Xue, X.; Yan, Y.; Han, L.; Xu, Z., 2015:
BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro

Naito, M.; Zager, R.A.; Bomsztyk, K., 2009:
BRG1 increases transcription of proinflammatory genes in renal ischemia

Bai, J.; Mei, P.; Zhang, C.; Chen, F.; Li, C.; Pan, Z.; Liu, H.; Zheng, J., 2013:
BRG1 is a prognostic marker and potential therapeutic target in human breast cancer

Wang, Y.; Gao, B.; Xu, W.; Xiong, S., 2011:
BRG1 is indispensable for IFN-γ-induced TRIM22 expression, which is dependent on the recruitment of IRF-1

Bartlett, C.; Orvis, T.J.; Rosson, G.S.; Weissman, B.E., 2011:
BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest

Yuan, Y.; Wang, C.; Xu, J.; Tao, J.; Xu, Z.; Huang, S., 2016:
BRG1 overexpression in smooth muscle cells promotes the development of thoracic aortic dissection

Davis, R.B.; Curtis, C.D.; Griffin, C.T., 2013:
BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development

Liu, X.; Tian, X.; Wang, F.; Ma, Y.; Kornmann, M.; Yang, Y., 2014:
BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling

Saladi, S.V.; Wong, P.G.; Trivedi, A.R.; Marathe, H.G.; Keenen, B.; Aras, S.; Liew, Z-Qi.; Setaluri, V.; de la Serna, I.L., 2013:
BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene

Qi, W.; Wang, R.; Chen, H.; Wang, X.; Xiao, T.; Boldogh, I.; Ba, X.; Han, L.; Zeng, X., 2016:
BRG1 promotes the repair of DNA double-strand breaks by facilitating the replacement of RPA with RAD51

Kim, S-Il.; Bultman, S.J.; Kiefer, C.M.; Dean, A.; Bresnick, E.H., 2009:
BRG1 requirement for long-range interaction of a locus control region with a downstream promoter

Xiong, X.; Xu, C.; Zhang, Y.; Li, X.; Wang, B.; Wang, F.; Yang, Q.; Wang, D.; Wang, X.; Li, S.; Chen, S.; Zhao, Y.; Yin, D.; Huang, Y.; Zhu, X.; Wang, L.; Wang, L.; Chang, L.; Xu, C.; Li, H.; Ke, T.; Ren, X.; Wu, Y.; Zhang, R.; Wu, T.; Xia, Y.; Yang, Y.; Ma, X.; Tu, X.; Wang, Q.K., 2014:
BRG1 variant rs1122608 on chromosome 19p13.2 confers protection against stroke and regulates expression of pre-mRNA-splicing factor SFRS3

Imbalzano, A.N.; Imbalzano, K.M.; Nickerson, J.A., 2013:
BRG1, a SWI/SNF chromatin remodeling enzyme ATPase, is required for maintenance of nuclear shape and integrity

Wurster, A.L.; Pazin, M.J., 2008:
BRG1-mediated chromatin remodeling regulates differentiation and gene expression of T helper cells

Orvis, T.; Hepperla, A.; Walter, V.; Song, S.; Simon, J.; Parker, J.; Wilkerson, M.D.; Desai, N.; Major, M.B.; Hayes, D.Neil.; Davis, I.J.; Weissman, B., 2015:
BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization

Hacham, Y.; Sela, A.; Friedlander, L.; Savaldi-Goldstein, S., 2012:
BRI1 activity in the root meristem involves post-transcriptional regulation of PIN auxin efflux carriers

Kim, J.; Miller, V.M.; Levites, Y.; West, K.Jansen.; Zwizinski, C.W.; Moore, B.D.; Troendle, F.J.; Bann, M.; Verbeeck, C.; Price, R.W.; Smithson, L.; Sonoda, L.; Wagg, K.; Rangachari, V.; Zou, F.; Younkin, S.G.; Graff-Radford, N.; Dickson, D.; Rosenberry, T.; Golde, T.E., 2008:
BRI2 (ITM2b) inhibits Abeta deposition in vivo

Tsachaki, M.; Ghiso, J.; Efthimiopoulos, S., 2009:
BRI2 as a central protein involved in neurodegeneration

Del Campo, M.; Oliveira, C.R.; Scheper, W.; Zwart, R.; Korth, C.; Müller-Schiffmann, A.; Kostallas, G.; Biverstal, H.; Presto, J.; Johansson, J.; Hoozemans, J.J.; Pereira, C.F.; Teunissen, C.E., 2015:
BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells

Tsachaki, M.; Ghiso, J.; Rostagno, A.; Efthimiopoulos, S., 2008:
BRI2 homodimerizes with the involvement of intermolecular disulfide bonds

Matsuda, S.; Giliberto, L.; Matsuda, Y.; McGowan, E.M.; D'Adamio, L., 2008:
BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate

Tsachaki, M.; Fotinopoulou, A.; Slavi, N.; Zarkou, V.; Ghiso, J.; Efthimiopoulos, S., 2014:
BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels

Kilger, E.; Buehler, A.; Woelfing, H.; Kumar, S.; Kaeser, S.A.; Nagarathinam, A.; Walter, J.; Jucker, M.; Coomaraswamy, J., 2011:
BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE)

Del Campo, M.; Hoozemans, J.J.M.; Dekkers, L-Lee.; Rozemuller, A.J.; Korth, C.; Müller-Schiffmann, A.; Scheltens, P.; Blankenstein, M.A.; Jimenez, C.R.; Veerhuis, R.; Teunissen, C.E., 2014:
BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease

Matsuda, S.; Matsuda, Y.; D'Adamio, L., 2009:
BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2

Hedlund, J.; Johansson, J.; Persson, B., 2009:
BRICHOS - a superfamily of multidomain proteins with diverse functions

Willander, H.; Hermansson, E.; Johansson, J.; Presto, J., 2011:
BRICHOS domain associated with lung fibrosis, dementia and cancer--a chaperone that prevents amyloid fibril formation?

Willander, H.; Presto, J.; Askarieh, G.; Biverstål, H.; Frohm, B.; Knight, S.D.; Johansson, J.; Linse, S., 2012:
BRICHOS domains efficiently delay fibrillation of amyloid β-peptide

Cammett, M.; Issar, S., 2010:
BRICKS AND MORTAR CLIENTELISM: Sectarianism and the Logics of Welfare Allocation in Lebanon

Anonymous, 2007:
BRICNet, a collaborative brazilian network to conduct and to promote multicenter studies in intensive care

Acharya, S.; Barber, S-Louise.; Lopez-Acuna, D.; Menabde, N.; Migliorini, L.; Molina, Jín.; Schwartländer, B.; Zurn, P., 2016:
BRICS and global health

Johnston, J.; Orrell, C.; Smith, P.; Joubert, A.; Wiesner, L., 2018:
A validated liquid chromatography/tandem mass spectrometry method for the analysis of efavirenz in 0.2 mg hair samples from human immunodeficiency virus infected patients

Barbosa da Silva Junior, J.; Desiraju, K.; Matsoso, P.; Minghui, R.; Salagay, O., 2016:
BRICS cooperation in strategic health projects

Cashwell, A.; Tantri, A.; Schmidt, A.; Simon, G.; Mistry, N., 2016:
BRICS in the response to neglected tropical diseases

Bhaumik, S., 2013:
BRICS nations agree to collaborate on research and public health challenges

Burki, T.Khan., 2012:
BRICS nations tackle non-communicable diseases

Keeton, C., 2016:
BRICS seek value for money as health-care costs rise

Kickbusch, I., 2016:
BRICS' contributions to the global health agenda

McKee, M.; Marten, R.; Balabanova, D.; Watt, N.; Huang, Y.; Finch, A.P.; Fan, V.Y.; Van Damme, W.; Tediosi, F.; Missoni, E., 2016:
BRICS' role in global health and the promotion of universal health coverage: the debate continues

Hyder, A.A.; Vecino-Ortiz, A.I., 2016:
BRICS: opportunities to improve road safety

Young, A.H.; Angst, J.; Azorin, J-Michel.; Vieta, E.; Perugi, G.; Gamma, A.; Bowden, C.L., 2013:
BRIDGE Study Warrants Critique-Reply

Allen, D.M.; Parry, P.I.; Purssey, R.; Spielmans, G.I.; Jureidini, J.; Rosenlicht, N.Z.; Healy, D.; Feinberg, I., 2012:
BRIDGE study warrants critique

Hainsworth, J.D.; Fang, L.; Huang, J.E.; Karlin, D.; Russell, K.; Faoro, L.; Azzoli, C., 2011:
BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer

Thomas, S., 1997:
BRIEF COMMUNICATION Geographic parthenogenesis in a tropical forest tree

Calonder, M.; Lepetit, V.; Özuysal, M.; Trzcinski, T.; Strecha, C.; Fua, P., 2011:
BRIEF: Computing a Local Binary Descriptor Very Fast

Bolshtyansky, M.A.; Tabiryan, N.V.; Zel'dovich, B.Y., 1997:
BRIEFING: beam reconstruction by iteration of an electromagnetic field with an induced nonlinearity gauge

Basit, A.; Khan, A.; Khan, R.Ali., 2014:
BRIGHT Guidelines on Self-Monitoring of Blood Glucose

Anonymous, 2010:
BRIGHTER blood for blue babies

Swift, L., 1892:
BRILLIANT AURORAe OF 1892

Young, K.; Minchom, A.; Larkin, J., 2012:
BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAF(V600E) mutation

Liu, L.; Long, Y.; Fieguth, P.W.; Lao, S.; Zhao, G., 2014:
BRINT: binary rotation invariant and noise tolerant texture classification

Frank, B.; Hemminki, K.; Meindl, A.; Wappenschmidt, B.; Sutter, C.; Kiechle, M.; Bugert, P.; Schmutzler, R.K.; Bartram, C.R.; Burwinkel, B., 2007:
BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study

Wong, M.W.; Nordfors, C.; Mossman, D.; Pecenpetelovska, G.; Avery-Kiejda, K.A.; Talseth-Palmer, B.; Bowden, N.A.; Scott, R.J., 2011:
BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer

Lam, M.O.; Disney, T.; Raicu, D.S.; Furst, J.; Channin, D.S., 2007:
BRISC-an open source pulmonary nodule image retrieval framework

Tan, A.; Tripp, B.; Daley, D., 2012:
BRISK--research-oriented storage kit for biology-related data

Zhang, B.; Wang, E.; Dai, H.; Hu, R.; Liang, Y.; Li, K.; Wang, G.; Peng, G.; Lin, S-Yih., 2013:
BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer

Giallongo, C.; Tibullo, D.; La Cava, P.; Branca, A.; Parrinello, N.; Spina, P.; Stagno, F.; Conticello, C.; Chiarenza, A.; Vigneri, P.; Palumbo, G.A.; Di Raimondo, F., 2012:
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint

Peng, G.; Lin, S-Yih., 2010:
BRIT1/MCPH1 is a multifunctional DNA damage responsive protein mediating DNA repair-associated chromatin remodeling

Liang, Y.; Gao, H.; Lin, S-Yih.; Peng, G.; Huang, X.; Zhang, P.; Goss, J.A.; Brunicardi, F.C.; Multani, A.S.; Chang, S.; Li, K., 2010:
BRIT1/MCPH1 is essential for mitotic and meiotic recombination DNA repair and maintaining genomic stability in mice

Anonymous, 2011:
BRITAIN is slow in adopting a standard iodised salt

Anonymous, 1948:
BRITAIN'S new health law

Yadav, P.Swaroop.; Prashar, P.; Bandyopadhyay, A., 2012:
BRITER: a BMP responsive osteoblast reporter cell line

Anonymous, 1948:
BRITISH (THE) medical and surgical adhesive plaster industry

Williams, M.; Martin, J.; Galettis, P., 2018:
A Validated Method for the Detection of Synthetic Cannabinoids in Oral Fluid

Anonymous, 1976:
BRITISH ASSOCIATION OF OTOLARYNGOLOGISTS: Excerpts from Annual Report of Council 1974/75

Anonymous, 1976:
BRITISH ASSOCIATION OF OTOLARYNGOLOGISTS: Excerpts from the Honorary Secretary's Newsletter, June 1976

Anonymous, 1911:
BRITISH ASSOCIATION: President's Address

Anonymous, 1911:
BRITISH ASSOCIATION: Section of Anthropology

Anonymous, 1911:
BRITISH ASSOCIATION: Section of Physiology

Anonymous, 1911:
BRITISH ASSOCIATION: Section of Zoology

Fox, R.F., 1915:
BRITISH HEALTH RESORTS IN PEACE AND WAR: Being the Third Chadwick Lecture, delivered at the Royal Society of Medicine, June 10th, 1915

Anonymous, 1948:
BRITISH Health Service Acts and the dental profession

Grimsdale, H., 1919:
BRITISH MASTERS OF OPHTHALMOLOGY SERIES: 9.-GEORGE JAMES GUTHRIE, F.R.S., (1785-1856). Founder of the Royal Westminster Ophthalmic Hospital

Fergus, F., 1917:
BRITISH MASTERS OF OPHTHALMOLOGY SERIES: I.-Sketch of the LIFE OF WILLIAM McKENZIE, M.D. (1791-1868.) Her Majesty's Oculist for Scotland. Surgeon to the Glasgow Eye Infirmary

Anonymous, 1928:
BRITISH MEDICAL ASSOCIATION XCVI ANNUAL MEETING, CARDIFF, 1928 Section of Ophthalmology, July 25 and 26

Anonymous, 2016:
BRITISH Medical Association and the National Health Service Bill

Anonymous, 2012:
BRITISH National Health Service Bill

Anonymous, 1960:
BRITISH PHARMACOLOGICAL SOCIETY and SCANDINAVIAN PHARMACOLOGICAL SOCIETY

Anonymous, 1963:
BRITISH PHARMACOLOGICAL SOCIETY, PROGRAMME OF MEETING, JULY 10 to 12

Anonymous, 1948:
BRITISH Pharmacopoeia, 1948; organic chemical substances

Anonymous, 1912:
BRITISH RED CROSS SOCIETY: Work in the Balkans

Anonymous, 1947:
BRITISH anti-lewisite; a new therapeutic agent

Anonymous, 2011:
BRITISH contribution to radiolocation

Anonymous, 2012:
BRITISH labour Government to replace health insurance by state medicine plan

Anonymous, 1946:
BRITISH penicillin mass produced

Anonymous, 1949:
BRITISH practice in dealing with unhealthy conditions of work

Anonymous, 2011:
BRITISH scientific instruments

Anonymous, 1945:
BRITISH veterinary colleges; the Royal Veterinary College and Hospital, London

Anonymous, 2010:
BRITISH veterinary periodicals

Anonymous, 1946:
BRITISH views on contact lens fitting

Hsia, M.Mandy.; Callis, J., 2011:
BRIZ1 and BRIZ2 proteins form a heteromeric E3 ligase complex required for seed germination and post-germination growth in Arabidopsis thaliana

Lukong, K.E.; Huot, M-Etienne.; Richard, Séphane., 2009:
BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest

Miah, S.; Goel, R.Kumar.; Dai, C.; Kalra, N.; Beaton-Brown, E.; Bagu, E.T.; Bonham, K.; Lukong, K.E., 2014:
BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration

Bock, V.L.; Lyons, J.G.; Huang, X.X.J.; Jones, A.M.; McDonald, L.A.; Scolyer, R.A.; Moloney, F.J.; Barnetson, R.Stc.; Halliday, G.M., 2012:
BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours

Bajpai, A.; Sridhar, S.; Reddy, H.M.; Jesudasan, R.A., 2008:
BRM-Parser: a tool for comprehensive analysis of BLAST and RepeatMasker results

Zhang, Y.; Chin-Quee, K.; Riddle, R.C.; Li, Z.; Zhou, Z.; Donahue, H.J., 2013:
BRMS1 Sensitizes Breast Cancer Cells to ATP-Induced Growth Suppression

Cicek, M.; Fukuyama, R.; Cicek, M.S.; Sizemore, S.; Welch, D.R.; Sizemore, N.; Casey, G., 2009:
BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter

Wu, Y.; McEwen, G.D.; Harihar, S.; Baker, S.M.; DeWald, D.B.; Zhou, A., 2010:
BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study

Sheng, X.J.; Zhou, D.M.; Liu, Q.; Lou, S.Y.; Song, Q.Y.; Zhou, Y.Q., 2014:
BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells

You, J.; He, X.; Ding, H.; Zhang, T., 2016:
BRMS1 regulates apoptosis in non-small cell lung cancer cells

Hedley, B.D.; Vaidya, K.S.; Phadke, P.; MacKenzie, L.; Dales, D.W.; Postenka, C.O.; MacDonald, I.C.; Chambers, A.F., 2008:
BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation

Mei, P.; Bai, J.; Shi, M.; Liu, Q.; Li, Z.; Fan, Y.; Zheng, J., 2015:
BRMS1 suppresses glioma progression by regulating invasion, migration and adhesion of glioma cells

Liu, Y.; Mayo, M.W.; Nagji, A.S.; Hall, E.H.; Shock, L.S.; Xiao, A.; Stelow, E.B.; Jones, D.R., 2013:
BRMS1 suppresses lung cancer metastases through an E3 ligase function on histone acetyltransferase p300

Nagji, A.S.; Liu, Y.; Stelow, E.B.; Stukenborg, G.J.; Jones, D.R., 2010:
BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer

Choi, H-Eun.; Yoo, M-Sang.; Choi, J-Hye.; Lee, J.Yeol.; Kim, J.Hak.; Kim, J.Han.; Lee, J.Kwang.; Kim, G.Il.; Park, Y.; Chi, Y.Ha.; Paik, S.Heui.; Lee, J.Han.; Lee, K-Tae., 2012:
BRN-103, a novel nicotinamide derivative, inhibits VEGF-induced angiogenesis and proliferation in human umbilical vein endothelial cells

Nachman, I.; Regev, A., 2009:
BRNI: Modular analysis of transcriptional regulatory programs

Spinar, J.; Ludka, O.; Sepsi, M.; Schildberger, J.; Dusek, L.; Jarkovský, J., 2010:
BRNO Register 2: post-myocardial infarction pharmacotherapy

Partridge, E.; Trobbiani, S.; Stockham, P.; Scott, T.; Kostakis, C., 2018:
A Validated Method for the Screening of 320 Forensically Significant Compounds in Blood by LC/QTOF, with Simultaneous Quantification of Selected Compounds

Eklund, A.; Dufort, P.; Villani, M.; Laconte, S., 2014:
BROCCOLI: Software for fast fMRI analysis on many-core CPUs and GPUs

De Biase, P.M.; Solano, C.J.F.; Markosyan, S.; Czapla, L.; Noskov, S.Yu., 2012:
BROMOC-D: Brownian Dynamics/Monte-Carlo Program Suite to Study Ion and DNA Permeation in Nanopores

Anonymous, 2016:
BROMPTON Hospital for consumption and diseases of the chest

Rowe, A.H.; Rowe, A., 1950:
BRONCHIAL ASTHMA IN ADULTS-Causes and Treatment

Scarlett, E.P., 1946:
BRONCHIECTASIS: (A Review)

Sundari, S.Karpagam.Kumara.; Kumarappan, C.T.; Jaswanth, A.; Valarmathy, R., 2004:
BRONCHODILATOR EFFECT OF ALCOHOLIC EXTRACT OF Euphorbia hirta linn

Anonymous, 2012:
BRONCHOGENIC carcinoma of the apical portion of the right lung, with widespread metastases

Anonymous, 1946:
BRONCHOPULMONARY actinomycosis

Lawler, A., 2007:
BROOKHAVEN LAB: Forbes Loses in Fallout From Reactor Fight

Anonymous, 2012:
BROTHER ISAIAH and Miracle Hill

Yoo, S.Jeon.; Chung, K.Sook.; Jung, S.Hye.; Yoo, S.Yeon.; Lee, J.Seob.; Ahn, J.Hoon., 2010:
BROTHER OF FT AND TFL1 (BFT) has TFL1-like activity and functions redundantly with TFL1 in inflorescence meristem development in Arabidopsis

Chung, K.Sook.; Yoo, S.Yeon.; Yoo, S.Jeon.; Lee, J.Seob.; Ahn, J.Hoon., 2011:
BROTHER OF FT AND TFL1 (BFT), a member of the FT/TFL1 family, shows distinct pattern of expression during the vegetative growth of Arabidopsis

Gaylor, J.B.; Howie, J.W., 1938:
BROWN-SÉQUARD SYNDROME: A Case of Unusual Ætiology

Quan, J.; Jin, M.; Xu, H.; Qiu, D.; Yin, X., 2014:
BRP, a polysaccharide fraction isolated from Boschniakia rossica, protects against galactosamine and lipopolysaccharide induced hepatic failure in mice

Guo, F.; Lin, P-Rong.; Li, Y-Qin.; Su, X-Li.; Wang, D-Ding.; Zhou, T-Hong., 2013:
BRPF2, a novel transcript of BRPF1 and their expression in mice tissues

Wang, Y.; Wan, B.; Zhou, J.; Li, R.; Yu, L., 2014:
BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation

Anonymous, 1946:
BRUCELLA abortus infection in cattle; agglutination tests

Anonymous, 2011:
BRUCELLOSIS (undulant fever)

Anonymous, 1948:
BRUCELLOSIS control program at the crossroads

Anonymous, 2010:
BRUCELLOSIS in Iowa; duration of illness

Anonymous, 1947:
BRUCELLOSIS versus neurosis; an attempt at an appraisal

Anonymous, 2012:
BRUCELLOSIS: treatment

Anonymous, 1947:
BRUSH cavalcade

Anonymous, 2014:
BRUTALITIES of Nazi physicians

Kühne, M.; Stuck, D.; Tegeler, E., 1982:
BRV-continuum source as a radiometric transfer standard between 40 nm and 600 nm

Beuchat, J.; Scacchi, E.; Tarkowska, D.; Ragni, L.; Strnad, M.; Hardtke, C.S., 2011:
BRX promotes Arabidopsis shoot growth

Breunig, C.; Mueller, B.J.; Umansky, L.; Wahl, K.; Hoffmann, K.; Lehner, F.; Manns, M.P.; Bantel, H.; Falk, C.S., 2015:
BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma

Jianu, D.Mihaela.; Streinu-Cercel, A.; Blidaru, A.; Filipescu, M.; Florescu, I.Petre.; Berciu, I.; Cobani, O.; Dorobăţ, O.; Jianu, S.Adrian.; Streinu-Cercel, O.; Stăniceanu, F.; Streinu-Cercel, A., 2014:
BReast Ecology Assessment in the STudy of local MicroFlora - Study Protocol

Chen, P-Yang.; Cokus, S.J.; Pellegrini, M., 2010:
BS Seeker: precise mapping for bisulfite sequencing

Hu, J.; Yan, X., 2012:
BS-KNN: An Effective Algorithm for Predicting Protein Subchloroplast Localization

Ellenbecker, C.Hall.; Kazmi, M., 2014:
BS-PhD programs in nursing: where are we now?

Guo, W.; Fiziev, P.; Yan, W.; Cokus, S.; Sun, X.; Zhang, M.Q.; Chen, P-Yang.; Pellegrini, M., 2014:
BS-Seeker2: a versatile aligning pipeline for bisulfite sequencing data

Ikeda, O.; Miyasaka, Y.; Yoshida, R.; Mizushima, A.; Oritani, K.; Sekine, Y.; Kuroda, M.; Yasui, T.; Fujimuro, M.; Muromoto, R.; Nanbo, A.; Matsuda, T., 2010:
BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-kappaB activation

Yu, B.; Shao, Y.; Zhang, C.; Chen, Y.; Zhong, Q.; Zhang, J.; Yang, H.; Zhang, W.; Wan, J., 2010:
BS69 undergoes SUMO modification and plays an inhibitory role in muscle and neuronal differentiation

Guo, R.; Zheng, L.; Park, J.Won.; Lv, R.; Chen, H.; Jiao, F.; Xu, W.; Mu, S.; Wen, H.; Qiu, J.; Wang, Z.; Yang, P.; Wu, F.; Hui, J.; Fu, X.; Shi, X.; Shi, Y.Geno.; Xing, Y.; Lan, F.; Shi, Y. , 2015:
BS69/ZMYND11 reads and connects histone H3.3 lysine 36 trimethylation-decorated chromatin to regulated pre-mRNA processing

Raut, S.L.; Rich, R.; Fudala, R.; Kokate, R.; Kimball, J.D.; Borejdo, J.; Vishwanatha, J.K.; Gryczynski, Z.; Gryczynski, I., 2015:
BSA Au clusters as a probe for enhanced fluorescence detection using multipulse excitation scheme

Yogasundaram, H.; Bahniuk, M.Stephan.; Singh, H-Deep.; Aliabadi, H.Montezari.; Uludağ, H.; Unsworth, L.David., 2012:
BSA Nanoparticles for siRNA Delivery: Coating Effects on Nanoparticle Properties, Plasma Protein Adsorption, and In Vitro siRNA Delivery

Ge, S.; Zhang, C.; Zhu, Y.; Yu, J.; Zhang, S., 2010:
BSA activated CdTe quantum dot nanosensor for antimony ion detection

Vallée, A.; Humblot, V.; Al Housseiny, R.; Boujday, S.; Pradier, C-Marie., 2013:
BSA adsorption on aliphatic and aromatic acid SAMs: investigating the effect of residual surface charge and sublayer nature

Baier, G.; Costa, C.; Zeller, A.; Baumann, D.; Sayer, C.; Araujo, P.H.H.; Mailänder, V.; Musyanovych, A.; Landfester, K., 2011:
BSA adsorption on differently charged polystyrene nanoparticles using isothermal titration calorimetry and the influence on cellular uptake

Wilhelmi, M.; Müller, C.; Ziegler, C.; Kopnarski, M., 2011:
BSA adsorption on titanium: ToF-SIMS investigation of the surface coverage as a function of protein concentration and pH-value

Carneiro, T.N.; Novaes, D.S.; Rabelo, R.B.; Celebi, B.; Chevallier, P.; Mantovani, D.; Beppu, M.M.; Vieira, R.S., 2014:
BSA and fibrinogen adsorption on chitosan/κ-carrageenan polyelectrolyte complexes

Vignesh, G.; Arunachalam, S.; Vignesh, S.; James, R.Arthur., 2013:
BSA binding and antimicrobial studies of branched polyethyleneimine-copper(II)bipyridine/phenanthroline complexes

Bugatti, A.; Chiodelli, P.; Rosenbluh, J.; Loyter, A.; Rusnati, M., 2010:
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: Prototype for the development of multitarget inhibitors of extracellular Tat

Sripriyalakshmi, S.; Anjali, C.H.; George, P.Doss.C.; Rajith, B.; Ravindran, A., 2014:
BSA nanoparticle loaded atorvastatin calcium--a new facet for an old drug

Garland, S.; Baker, A.; Phillott, A.D.; Skerratt, L.F., 2011:
BSA reduces inhibition in a TaqMan assay for the detection of Batrachochytrium dendrobatidis

Kim, B.Soo.; Oh, J.Min.; Kim, K.Sook.; Seo, K.Soo.; Cho, J.Song.; Khang, G.; Lee, H.Bang.; Park, K.; Kim, M.Suk., 2008:
BSA-FITC-loaded microcapsules for in vivo delivery

Chitkara, D.; Kumar, N., 2014:
BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs

Narla, S.Nandana.; Pinnamaneni, P.; Nie, H.; Li, Y.; Sun, X-Long., 2014:
BSA-boronic acid conjugate as lectin mimetics

Zheng, X-Shan.; Hu, P.; Cui, Y.; Zong, C.; Feng, J-Min.; Wang, X.; Ren, B., 2015:
BSA-coated nanoparticles for improved SERS-based intracellular pH sensing

Wang, H.; He, Y.; He, X.; Li, W.; Chen, L.; Zhang, Y., 2009:
BSA-imprinted synthetic receptor for reversible template recognition

Liu, Z.; Deng, X.; Wang, M.; Chen, J.; Zhang, A.; Gu, Z.; Zhao, C., 2009:
BSA-modified polyethersulfone membrane: preparation, characterization and biocompatibility

Wang, X-Xiang.; Wu, Q.; Shan, Z.; Huang, Q-Ming., 2011:
BSA-stabilized Au clusters as peroxidase mimetics for use in xanthine detection

Li, D.; Wang, H.; Kong, D.; Yang, Z., 2012:
BSA-stabilized molecular hydrogels of a hydrophobic compound

Liu, X.; Wang, Q.; Zhao, H.; Zhang, L.; Su, Y.; Lv, Y., 2013:
BSA-templated MnO2 nanoparticles as both peroxidase and oxidase mimics

Xu, J-Ping.; Fang, Y.; Song, Z-Gang.; Mei, J.; Jia, L.; Qin, A.Jun.; Sun, J.Zhi.; Ji, J.; Tang, B.Zhong., 2011:
BSA-tetraphenylethene derivative conjugates with aggregation-induced emission properties: fluorescent probes for label-free and homogeneous detection of protease and α1-antitrypsin

Andrews, J.M.; Howe, R.A., 2012:
BSAC standardized disc susceptibility testing method (version 10)

Howe, R.A.; Andrews, J.M., 2013:
BSAC standardized disc susceptibility testing method (version 11)

Andrews, J.M., 2009:
BSAC standardized disc susceptibility testing method (version 8)

Luyt, D.; Ball, H.; Makwana, N.; Green, M.R.; Bravin, K.; Nasser, S.M.; Clark, A.T., 2014:
BSACI guideline for the diagnosis and management of cow's milk allergy

Ewan, P.W.; Dugué, P.; Mirakian, R.; Dixon, T.A.; Harper, J.N.; Nasser, S.M., 2010:
BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia

Mirakian, R.; Ewan, P.W.; Durham, S.R.; Youlten, L.J.F.; Dugué, P.; Friedmann, P.S.; English, J.S.; Huber, P.A.J.; Nasser, S.M., 2009:
BSACI guidelines for the management of drug allergy

Anonymous, 2011:
BSAVA award winners 2011

Anonymous, 2014:
BSAVA calls for vets to be eligible for pre-exposure rabies vaccination

Anonymous, 2013:
BSAVA president warns of consequences of irresponsible use of antimicrobials

Anonymous, 2011:
BSAVA's client leaflets help explain off-label medicines use

Aung, Z.; Tong, J.Chuan., 2009:
BSAlign: a rapid graph-based algorithm for detecting ligand-binding sites in protein structures

Kocjan, G.; Chandra, A.; Cross, P.; Denton, K.; Giles, T.; Herbert, A.; Smith, P.; Remedios, D.; Wilson, P., 2009:
BSCC Code of Practice--fine needle aspiration cytology

Cochand-Priollet, B., 2009:
BSCC code of practice for non-gynaecological cytology: what are the next steps?

Monteiro, A.; Real, R.; Nadais, G.; Silveira, F.; Leão, M., 2015:
BSCL2 N88S mutation in a Portuguese patient with the Silver syndrome

Ito, D.; Yagi, T.; Suzuki, N., 2012:
BSCL2-related neurologic disorders/seipinopathy: endoplasmic reticulum stress in neurodegeneration

Yang, W.; Thein, S.; Wang, X.; Bi, X.; Ericksen, R.E.; Xu, F.; Han, W., 2014:
BSCL2/seipin regulates adipogenesis through actin cytoskeleton remodelling

Babbin, F., 1966:
BSCS: Its Impractical Aspects

Zhang, Z.; Chen, H.; Huang, X.; Xia, R.; Zhao, Q.; Lai, J.; Teng, K.; Li, Y.; Liang, L.; Du, Q.; Zhou, X.; Guo, H.; Xie, Q., 2011:
BSCTV C2 attenuates the degradation of SAMDC1 to suppress DNA methylation-mediated gene silencing in Arabidopsis

Yang, M.; Zhao, J.; Wang, Y., 2010:
BSD2000 deep hyperthermia combined with chemotherapy of PT regimen in patients with non-small cell lung cancer

Sikora, M.; Sulkowska, J.I.; Witkowski, B.S.; Cieplak, M., 2011:
BSDB: the biomolecule stretching database

Changela, J.J., 1985:
BSE Cancerphobia? Not Seen by this FP

Richt, Jürgen.A.; Hall, S.Mark., 2008:
BSE case associated with prion protein gene mutation

Cima, G., 2012:
BSE found in dairy cow

Di Guardo, G., 2014:
BSE in buffaloes

Hoffmann, C.; Eiden, M.; Kaatz, M.; Keller, M.; Ziegler, U.; Rogers, R.; Hills, B.; Balkema-Buschmann, A.; van Keulen, L.; Jacobs, J.G.; Groschup, M.H., 2014:
BSE infectivity in jejunum, ileum and ileocaecal junction of incubating cattle

Balkema-Buschmann, A.; Eiden, M.; Hoffmann, C.; Kaatz, M.; Ziegler, U.; Keller, M.; Groschup, M.H., 2011:
BSE infectivity in the absence of detectable PrP(Sc) accumulation in the tongue and nasal mucosa of terminally diseased cattle

Richards, K., 2007:
BSE terminology

Jones, K.E., 2009:
BSE, risk and the communication of uncertainty: a review of Lord Phillips' report from the BSE inquiry (UK)

Vernerova, K.; Tothova, L.; Mikova, A.; Vodrazka, P.; Simek, B.; Hanusova, L.; Citek, J., 2015:
BSE-associated polymorphisms in the prion protein gene: an investigation

Krasemann, S.; Mearini, G.; Krämer, E.; Wagenführ, K.; Schulz-Schaeffer, W.; Neumann, M.; Bodemer, W.; Kaup, F-Josef.; Beekes, M.; Carrier, L.; Aguzzi, A.; Glatzel, M., 2013:
BSE-associated prion-amyloid cardiomyopathy in primates

Acín, C., 2013:
BSE: the further we go, the less we know

Morris, A., 2011:
BSE: where are we now?

Chen, Y.; Han, K., 2009:
BSFINDER: finding binding sites of HCV proteins using a support vector machine

Anonymous, 1992:
BSG Incoming President's Biography

Bouchier, I.A., 1995:
BSG President's Report for 1994-5

Anonymous, 1995:
BSG President's biography

Williams, R., 1991 :
BSG President's report

Hobsley, M., 1994:
BSG President's report for 1992-93

Losowsky, M.S., 1995:
BSG President's report for 1993-4

Anonymous, 1990:
BSG Presidents

Zimmermann, G.W., 2015:
BSG sets limits for clinics in EBM accounting

Shi, C.; Fasshuber, H.K.; Chevelkov, V.; Xiang, S.; Habenstein, B.; Vasa, S.Kumar.; Becker, S.; Lange, A., 2014:
BSH-CP based 3D solid-state NMR experiments for protein resonance assignment

James, J., 2013:
BSI not CSI: birth scene investigation--a community midwifery simulation

Nakamura, M.; Fukumitsu, N.; Kamizawa, S.; Numajiri, H.; Nemoto Murofushi, K.; Ohnishi, K.; Aihara, T.; Ishikawa, H.; Okumura, T.; Tsuboi, K.; Sakurai, H., 2018:
A validated proton beam therapy patch-field protocol for effective treatment of large hepatocellular carcinoma

Zou, Q.; Yan, R.; Liu, W.; Wei, P., 2018:
A Validated Quantification Method for Brexpiprazole in Dog Plasma

Shi, H.; Yan, H.; Li, J.; Tang, D., 2014:
BSK1, a receptor-like cytoplasmic kinase, involved in both BR signaling and innate immunity in Arabidopsis

Rodriguez, J.; Siahmakoun, A.; Salamo, G.; Miller, M.J.; Clark Iii, W.W.; Wood, G.L.; Sharp, E.J.; Neurgaonkar, R.R., 1987 :
BSKNN as a self-pumped phase conjugator

Richards, S.L.; Pompei, V.C.; Anderson, A., 2014:
BSL-3 laboratory practices in the United States: comparison of select agent and non-select agent facilities

Khalidov, I.; Van De Ville, D.; Jacob, M.; Lazeyras, Fçois.; Unser, M., 2007:
BSLIM: spectral localization by imaging with explicit B0 field inhomogeneity compensation

Maere, T.; Verrecht, B.; Moerenhout, S.; Judd, S.; Nopens, I., 2011:
BSM-MBR: a benchmark simulation model to compare control and operational strategies for membrane bioreactors

Xi, Y.; Li, W., 2009:
BSMAP: whole genome bisulfite sequence MAPping program

Cui, J.; Xu, L.; Bressler, S.L.; Ding, M.; Liang, H., 2008:
BSMART: a Matlab/C toolbox for analysis of multichannel neural time series

Milz, B.; Schnurr, P.; Grafmüller, J.; Oehler, K.; Spangenberg, B., 2018:
A Validated Quantification of Sudan Red Dyes in Spicery using TLC and a 16-bit Flatbed Scanner

Duffy, M.T.; Friesen, M.Ann.; Speroni, K.Gabel.; Swengros, D.; Shanks, L.A.; Waiter, P.A.; Sheridan, M.J., 2014:
BSN completion barriers, challenges, incentives, and strategies

Hermann, M.L.; Jones, B.; Winterhalter, J., 2013:
BSN graduates' perceptions of liberal education

Wang, J.; Wang, L.; Xia, B.; Yang, C.; Lai, H.; Chen, X., 2013:
BSP gene silencing inhibits migration, invasion, and bone metastasis of MDA-MB-231BO human breast cancer cells

Innes, E.A.; Rose, J.B.; Cook, N.; Hadfield, S.J.; Pollock, K.G.J.; Robertson, L.; Kusel, J.; Doenhoff, M.; Smith, H., 2011:
BSP remembers Professor Huw Smith

Lee, H.Sun.; Zhang, Y., 2012:
BSP-SLIM: a blind low-resolution ligand-protein docking approach using predicted protein structures

Neske, F.; Schörner, C.; Buchheit, K-Heinz.; Costanzo, Aèle.; Hanschmann, K-Martin.; Himly, M.; Holzhauser, T.; Ferreira, F.; Kaul, S.; Vieths, S.; van Ree, R., 2010:
BSP090--the follow-up to CREATE

Davies, K.; Cleary, G.; Foster, H.; Hutchinson, E.; Baildam, E., 2011:
BSPAR Standards of Care for children and young people with juvenile idiopathic arthritis

Baildam, E.; Davidson, J., 2008:
BSPAR position statement on professionals working in paediatric rheumatology

Donoghue, P.; Byrne, J.; Pennington, K., 2008:
BSPR/EBI 2007 meeting report--Integrative Proteomics: From Molecules to Systems. July 25-27, 2007 Wellcome Trust Conference Centre, Hinxton, UK

Kulig, J.; Feil, W.; Szczepanik, A., 2012:
BSQ examination in general surgery strikes back

He, X.; Li, Y.; Khetani, R.; Sanders, B.; Lu, Y.; Ling, X.; Zhai, C.; Schatz, B., 2010:
BSQA: integrated text mining using entity relation semantics extracted from biological literature of insects

Jobanputra, P., 2008:
BSR DMARD monitoring guidelines: sulfasalazine

Ntatsaki, E.; Carruthers, D.; Chakravarty, K.; D'Cruz, D.; Harper, L.; Jayne, D.; Luqmani, R.; Mills, J.; Mooney, J.; Venning, M.; Watts, R.A., 2015:
BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis

Dasgupta, B.; Borg, F.A.; Hassan, N.; Alexander, L.; Barraclough, K.; Bourke, B.; Fulcher, J.; Hollywood, J.; Hutchings, A.; James, P.; Kyle, V.; Nott, J.; Power, M.; Samanta, A., 2011:
BSR and BHPR guidelines for the management of giant cell arteritis

Dasgupta, B.; Borg, F.A.; Hassan, N.; Barraclough, K.; Bourke, B.; Fulcher, J.; Hollywood, J.; Hutchings, A.; Kyle, V.; Nott, J.; Power, M.; Samanta, A., 2010:
BSR and BHPR guidelines for the management of polymyalgia rheumatica

Bukhari, M.; Abernethy, R.; Deighton, C.; Ding, T.; Hyrich, K.; Lunt, M.; Luqmani, R.; Kiely, P.; Bosworth, A.; Ledingham, J.; Ostör, A.; Gadsby, K.; McKenna, F.; Finney, D.; Dixey, J., 2012:
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis

Deighton, C.; Hyrich, K.; Ding, T.; Ledingham, J.; Lunt, M.; Luqmani, R.; Kiely, P.; Bukhari, M.; Abernethy, R.; Ostor, A.; Bosworth, A.; Gadsby, K.; McKenna, F.; Finney, D.; Dixey, J., 2011:
BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy

Ding, T.; Ledingham, J.; Luqmani, R.; Westlake, S.; Hyrich, K.; Lunt, M.; Kiely, P.; Bukhari, M.; Abernethy, R.; Bosworth, A.; Ostor, A.; Gadsby, K.; McKenna, F.; Finney, D.; Dixey, J.; Deighton, C., 2011:
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

Li, L.; Huang, D.; Cheung, M.Kit.; Nong, W.; Huang, Q.; Kwan, H.Shan., 2013:
BSRD: a repository for bacterial small regulatory RNA

Lu, I-Cheng.; Yen Jean, M-Chu.; Lei, S-Meng.; Cheng, H-Huo.; Wang, J-Der., 2012:
BSRS-5 (5-item Brief Symptom Rating Scale) scores affect every aspect of quality of life measured by WHOQOL-BREF in healthy workers

Vigario, R.; Oja, E., 2012 :
BSS and ICA in neuroinformatics: from current practices to open challenges

Moiz, B.; Rashid, A., 2013:
BSS misdiagnosed as ITP

Xiong, B.; Wu, J.; Burk, D.L.; Xue, M.; Jiang, H.; Shen, J., 2010:
BSSF: a fingerprint based ultrafast binding site similarity search and function analysis server

Andersson, E-Lotta.; Hernell, O.; Bläckberg, L.; Fält, H.; Lindquist, S., 2012:
BSSL and PLRP2: key enzymes for lipid digestion in the newborn examined using the Caco-2 cell line

Scott, B.J.J., 2014:
BSSPD Annual Conference. Apex Hotel, Dundee 14th - 15th April 2014

Zhang, J.; Liang, C., 2010:
BST-2 diminishes HIV-1 infectivity

Amet, T.; Byrd, D.; Hu, N.; Sun, Q.; Li, F.; Zhao, Y.; Hu, S.; Grantham, A.; Yu, Q., 2014:
BST-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus

Skasko, M.; Tokarev, A.; Chen, C-Chang.; Fischer, W.B.; Pillai, S.K.; Guatelli, J., 2011:
BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: evidence for a post-ER mechanism of Vpu-action

Ruiz, A.; Lau, D.; Mitchell, R.S.; Hill, M.Sarah.; Schmitt, K.; Guatelli, J.C.; Stephens, E.B., 2010:
BST-2 mediated restriction of simian-human immunodeficiency virus

Jones, P.H.; Mahauad-Fernandez, W.D.; Madison, M.N.; Okeoma, C.M., 2013:
BST-2/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer

Evans, D.T.; Serra-Moreno, R.; Singh, R.K.; Guatelli, J.C., 2010:
BST-2/tetherin: a new component of the innate immune response to enveloped viruses

Gustin, J.K.; Douglas, J.L., 2014:
BST-2/tetherin: viral tether, viral sensor or both?

Chen, M-Ling.; Lin, C-Hsien.; Lee, M-Jen.; Wu, R-Meei., 2014:
BST1 rs11724635 interacts with environmental factors to increase the risk of Parkinson's disease in a Taiwanese population

Wang, S-Mei.; Huang, K-Jung.; Wang, C-Tien., 2014:
BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface

Viswanathan, K.; Smith, M.Shane.; Malouli, D.; Mansouri, M.; Nelson, J.A.; Früh, K., 2012:
BST2/Tetherin enhances entry of human cytomegalovirus

Epeldegui, M.; Blom, B.; Uittenbogaart, C.H., 2015:
BST2/Tetherin is constitutively expressed on human thymocytes with the phenotype and function of Treg cells

Pan, X-Ben.; Han, J-Chao.; Cong, X.; Wei, L., 2013:
BST2/tetherin inhibits dengue virus release from human hepatoma cells

Yao, Y.; Suraokar, M.; Darnay, B.G.; Hollier, B.G.; Shaiken, T.E.; Asano, T.; Chen, C-Hung.; Chang, B.H-J.; Lu, Y.; Mills, G.B.; Sarbassov, D.; Mani, S.A.; Abbruzzese, J.L.; Reddy, S.A.G., 2013:
BSTA promotes mTORC2-mediated phosphorylation of Akt1 to suppress expression of FoxC2 and stimulate adipocyte differentiation

Livaja, M.; Wang, Y.; Wieckhorst, S.; Haseneyer, G.; Seidel, M.; Hahn, V.; Knapp, S.J.; Taudien, S.; Schön, C-Carolin.; Bauer, E., 2014:
BSTA: a targeted approach combines bulked segregant analysis with next- generation sequencing and de novo transcriptome assembly for SNP discovery in sunflower

Anonymous, 2010:
BSVA policy on fireworks

Sterz, J.; Jakob, C.; Kuckelkorn, U.; Heider, U.; Mieth, M.; Kleeberg, L.; Kaiser, M.; Kloetzel, P-M.; Sezer, O.; von Metzler, I., 2010:
BSc2118 is a novel proteasome inhibitor with activity against multiple myeloma

Lin, X.; Sun, D.; Rodriguez, B.; Zhao, Q.; Sun, H.; Zhang, Y.; Li, W., 2014:
BSeQC: quality control of bisulfite sequencing experiments

Akhbardeh, A.; Kaminska, B.; Tavakolian, K., 2007:
BSeg++: a modified blind segmentation method for Ballistocardiogram cycle extraction

Gorochowski, T.E.; Matyjaszkiewicz, A.; Todd, T.; Oak, N.; Kowalska, K.; Reid, S.; Tsaneva-Atanasova, K.T.; Savery, N.J.; Grierson, C.S.; di Bernardo, M., 2013:
BSim: an agent-based tool for modeling bacterial populations in systems and synthetic biology

Kogut, M.H.; Genovese, K.J.; He, H.; Swaggerty, C.L.; Jiang, Y.Wei., 2012:
BT cationic peptides: small peptides that modulate innate immune responses of chicken heterophils and monocytes

Chamberlain, M.; Esquivel, J.; Miller, F.; Patmore, J., 2015:
BT's adoption of customer centric design

Shin, K.Young.; Won, B.Young.; Heo, C.; Kim, H.Jin.; Jang, D-Pyo.; Park, C.Hyoung.; Kim, S.; Kim, H-Sun.; Kim, Y-Bo.; Lee, H.Gun.; Lee, S.Hyung.; Cho, Z-Hee.; Suh, Y-Hun., 2009:
BT-11 improves stress-induced memory impairments through increment of glucose utilization and total neural cell adhesion molecule levels in rat brains

Shin, K.Young.; Lee, J-Young.; Won, B.Young.; Jung, H.Yeon.; Chang, K-A.; Koppula, S.; Suh, Y-Hun., 2010:
BT-11 is effective for enhancing cognitive functions in the elderly humans

Hunter, J.; Freer, Y.; Gatt, A.; Reiter, E.; Sripada, S.; Sykes, C.; Westwater, D., 2012:
BT-Nurse: computer generation of natural language shift summaries from complex heterogeneous medical data

Pardo, A.G., 2012:
BT-engineered bugs versus insect pests

Yenicesu, I.; Dilsiz, G.; Sucak, G.; Aki, Z., 2008:
BT-online: an innovated and promising computer assisted transfusion system

Mandadi, K.K.; Misra, A.; Ren, S.; McKnight, T.D., 2009:
BT2, a BTB protein, mediates multiple responses to nutrients, stresses, and hormones in Arabidopsis

Harusato, A.; Naito, Y.; Takagi, T.; Uchiyama, K.; Mizushima, K.; Hirai, Y.; Higashimura, Y.; Katada, K.; Handa, O.; Ishikawa, T.; Yagi, N.; Kokura, S.; Ichikawa, H.; Muto, A.; Igarashi, K.; Yoshikawa, T., 2013:
BTB and CNC homolog 1 (Bach1) deficiency ameliorates TNBS colitis in mice: role of M2 macrophages and heme oxygenase-1

Fujiyama-Nakamura, S.; Ito, S.; Sawatsubashi, S.; Yamauchi, Y.; Suzuki, E.; Tanabe, M.; Kimura, S.; Murata, T.; Isobe, T.; Takeyama, K-ichi.; Kato, S., 2010:
BTB protein, dKLHL18/CG3571, serves as an adaptor subunit for a dCul3 ubiquitin ligase complex

Catarinella, M.; Grüner, T.; Strittmatter, T.; Marx, A.; Mayer, T.U., 2010:
BTB-1: a small molecule inhibitor of the mitotic motor protein Kif18A

Marshall, J.; Blair, L.A.C.; Singer, J.D., 2011:
BTB-Kelch proteins and ubiquitination of kainate receptors

Byun, B.; Tak, H.; Joe, C.O., 2008:
BTB/POZ domain of speckle-type POZ protein (SPOP) confers proapoptotic function in HeLa cells

Alonso, C.N.; Meyer, C.; Gallego, M.S.; Rossi, J.G.; Mansini, Aán.P.; Rubio, P.L.; Medina, A.; Marschalek, R.; Felice, Mía.S., 2010:
BTBD18: A novel MLL partner gene in an infant with acute lymphoblastic leukemia and inv(11)(q13;q23)

Matsui, A.; Tran, M.; Yoshida, A.C.; Kikuchi, S.S.; U, M.; Ogawa, M.; Shimogori, T., 2013:
BTBD3 controls dendrite orientation toward active axons in mammalian neocortex

Lewis, F.W.; Harwood, L.M.; Hudson, M.J.; Drew, M.G.B.; Hubscher-Bruder, Véronique.; Videva, V.; Arnaud-Neu, Fçoise.; Stamberg, K.; Vyas, S., 2013:
BTBPs versus BTPhens: some reasons for their differences in properties concerning the partitioning of minor actinides and the advantages of BTPhens

Hudkins, K.L.; Pichaiwong, W.; Wietecha, T.; Kowalewska, J.; Banas, M.C.; Spencer, M.W.; Mühlfeld, A.; Koelling, M.; Pippin, J.W.; Shankland, S.J.; Askari, B.; Rabaglia, M.E.; Keller, M.P.; Attie, A.D.; Alpers, C.E., 2010:
BTBR Ob/Ob mutant mice model progressive diabetic nephropathy

Li, D.; Ma, S.; Yang, Y.; Yang, D.; Li, G.; Zhang, X.; Zhu, J.; Sun, M.; Tang, B., 2011:
BTEB2 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model

Liu, X.; Yuan, D.; Nie, X.; Shen, J.; Yan, Y.; Zhang, D.; Gu, J., 2015:
BTEB2 prevents neuronal apoptosis via promoting bad phosphorylation in rat intracerebral hemorrhage model

Wang, M.; Xie, H.; Stellpflug, W.; Rajaram, V.; Bonaldo, M.de.Fatima.; Goldman, S.; Tomita, T.; Soares, M.Bento., 2011:
BTECH: a platform to integrate genomic, transcriptomic and epigenomic alterations in brain tumors

Al Rayes, L.; Saliba, C.O.; Ghanem, A.; Randon, J., 2014:
BTES and aldehydes analysis in PET-bottled water in Lebanon

Tohon, H.Gbèdolo.; Fayomi, B.; Valcke, M.; Coppieters, Y.; Bouland, C., 2015 :
BTEX air concentrations and self-reported common health problems in gasoline sellers from Cotonou, Benin

Aivalioti, M.; Vamvasakis, I.; Gidarakos, E., 2010:
BTEX and MTBE adsorption onto raw and thermally modified diatomite

Mazzeo, Dânia.Elisa.Christofoletti.; Levy, C.Emílio.; de Angelis, D.de.Franceschi.; Marin-Morales, M.Aparecida., 2010:
BTEX biodegradation by bacteria from effluents of petroleum refinery

Franco, M.; Chairez, I.; Poznyak, T.; Poznyak, A., 2012:
BTEX decomposition by ozone in gaseous phase

Kim, B-Mi.; Park, E.kyo.; LeeAn, S-Young.; Ha, M.; Kim, E-Jung.; Kwon, H.; Hong, Y-Chul.; Jeong, W-Chul.; Hur, J.; Cheong, H-Kwan.; Yi, J.; Kim, J.Ho.; Lee, B-Eun.; Seo, J-Hee.; Chang, M-Hee.; Ha, E-Hee., 2009:
BTEX exposure and its health effects in pregnant women following the Hebei Spirit oil spill

Corseuil, H.X.; Monier, A.L.; Fernandes, M.; Schneider, M.R.; Nunes, C.C.; do Rosario, M.; Alvarez, P.J.J., 2011:
BTEX plume dynamics following an ethanol blend release: geochemical footprint and thermodynamic constraints on natural attenuation

Zhou, Q-Wei.; Zhu, R-Ye.; Hu, J.; Zhang, L-Li.; Chen, J-Meng., 2013:
BTF performance treating a chlorobenzene-contaminated gas stream

Conte, D.; MacWilliams, H.K.; Ceccarelli, A., 2011:
BTG interacts with retinoblastoma to control cell fate in Dictyostelium

Mauxion, F.; Chen, C-Ying.A.; Séraphin, B.; Shyu, A-Bin., 2010:
BTG/TOB factors impact deadenylases

Sheng, S.H.; Zhao, C.M.; Sun, G.G., 2014:
BTG1 expression correlates with the pathogenesis and progression of breast carcinomas

Zhao, Y.; Gou, W-Feng.; Chen, S.; Takano, Y.; Xiu, Y-Ling.; Zheng, H-Chuan., 2014:
BTG1 expression correlates with the pathogenesis and progression of ovarian carcinomas

Lu, Y.F.; Sun, G.G.; Liu, Q.; Yang, C.R.; Cheng, Y.J., 2015:
BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker

Zhu, R.; Zou, S-Tao.; Wan, J-Mei.; Li, W.; Li, X-Li.; Zhu, W., 2014:
BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis

van Galen, J.C.; Kuiper, R.P.; van Emst, L.; Levers, M.; Tijchon, E.; Scheijen, B.; Waanders, Eé.; van Reijmersdal, S.V.; Gilissen, C.; van Kessel, A.Geurts.; Hoogerbrugge, P.M.; van Leeuwen, F.N., 2010:
BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia

Sun, G.G.; Wang, Y.D.; Cheng, Y.J.; Hu, W.N., 2015:
BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma

Wheaton, K.; Muir, J.; Ma, W.; Benchimol, S., 2011:
BTG2 antagonizes Pin1 in response to mitogens and telomere disruption during replicative senescence

Hu, X-Dong.; Meng, Q-Hui.; Xu, J-Ying.; Jiao, Y.; Ge, C-Min.; Jacob, A.; Wang, P.; Rosen, E.M.; Fan, S., 2011:
BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity

Hu, X.; Xing, L.; Jiao, Y.; Xu, J.; Wang, X.; Han, A.; Yu, J., 2014:
BTG2 overexpression increases the radiosensitivity of breast cancer cells in vitro and in vivo

Mao, B.; Zhang, Z.; Wang, G., 2015:
BTG2: a rising star of tumor suppressors (review)

Majid, S.; Dar, A.A.; Ahmad, A.E.; Hirata, H.; Kawakami, K.; Shahryari, V.; Saini, S.; Tanaka, Y.; Dahiya, A.V.; Khatri, G.; Dahiya, R., 2009:
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer

Peng, J., 2012:
BTJ - looking back to look ahead

Anonymous, 2009:
BTJ Forum: Biotech in the financial crisis

Váncsa, A.; Tóth, Báta.; Szekanecz, Zán., 2011:
BTK gene mutation in two non-identical twins with X-linked agammaglobulinemia associated with polyarticular juvenile idiopathic arthritis

Edwards, C.M., 2012:
BTK inhibition in myeloma: targeting the seed and the soil

Rushworth, S.A.; Bowles, K.M.; Barrera, L.N.; Murray, M.Y.; Zaitseva, L.; MacEwan, D.J., 2013:
BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κB

Rousseau, Fçois.; Oubel, E.; Pontabry, J.; Schweitzer, M.; Studholme, C.; Koob, Mériam.; Dietemann, J-Louis., 2013:
BTK: an open-source toolkit for fetal brain MR image processing

Xu, X-Sheng.; Zhang, Z.; Gu, L-Lan.; Wang, F-Sheng., 2016:
BTLA Characterization and its association with disease progression in patients with chronic HIV-1 infection.

Sherwood, E.R.; Hotchkiss, R.S., 2015:
BTLA as a biomarker and mediator of sepsis-induced immunosuppression

Zeng, J-Cheng.; Lin, D-Zi.; Yi, L-Long.; Liu, G-Bin.; Zhang, H.; Wang, W-Dang.; Zhang, J-Ai.; Wu, X-Jing.; Xiang, W-Yu.; Kong, B.; Chen, Z.W.; Wang, C-Yi.; Xu, J-Fa., 2014:
BTLA exhibits immune memory for αβ T cells in patients with active pulmonary tuberculosis

Shubin, N.J.; Chung, C.S.; Heffernan, D.S.; Irwin, L.R.; Monaghan, S.F.; Ayala, A., 2012:
BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction

Steinberg, M.W.; Huang, Y.; Wang-Zhu, Y.; Ware, C.F.; Cheroutre, H.; Kronenberg, M., 2014:
BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection

Derré, L.; Rivals, J-Paul.; Jandus, C.; Pastor, S.; Rimoldi, D.; Romero, P.; Michielin, O.; Olive, D.; Speiser, D.E., 2010:
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination

Truong, W.; Hancock, W.W.; Plester, J.C.; Merani, S.; Rayner, D.C.; Thangavelu, G.; Murphy, K.M.; Anderson, C.C.; Shapiro, A.M.James., 2009:
BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice

Gertner-Dardenne, J.; Fauriat, C.; Olive, D., 2013:
BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation

Padilla-López, S.; Langager, D.; Chan, C-Hung.; Pearce, D.A., 2012:
BTN1, the Saccharomyces cerevisiae homolog to the human Batten disease gene, is involved in phospholipid distribution

Smith, I.A.; Knezevic, B.R.; Ammann, J.U.; Rhodes, D.A.; Aw, D.; Palmer, D.B.; Mather, I.H.; Trowsdale, J., 2010:
BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation

Le Page, Cécile.; Marineau, A.; Bonza, P.K.; Rahimi, K.; Cyr, L.; Labouba, I.; Madore, J.; Delvoye, N.; Mes-Masson, A-Marie.; Provencher, D.M.; Cailhier, J-François., 2012:
BTN3A2 expression in epithelial ovarian cancer is associated with higher tumor infiltrating T cells and a better prognosis

Yang, C.; Pan, L.; Zhang, L.; Wu, X.; Zhu, X.; Yan, B.; Xu, A.; Li, H.; Liu, Y., 2015:
BTNL2 associated with the immune response to hepatitis B vaccination in a Chinese Han population

Hsueh, K-Chung.; Lin, Y-Ju.; Chang, J-Sheng.; Wan, L.; Tsai, F-Jen., 2010:
BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children

Chapoval, A.I.; Smithson, G.; Brunick, L.; Mesri, M.; Boldog, F.L.; Andrew, D.; Khramtsov, N.V.; Feshchenko, E.A.; Starling, G.C.; Mezes, P.S., 2013:
BTNL8, a butyrophilin-like molecule that costimulates the primary immune response

Benay, G.; Schurhammer, R.; Wipff, G., 2010:
BTP-based ligands and their complexes with Eu(3+) at "oil"/water interfaces. A molecular dynamics study

O'Driscoll, B.R.; Howard, L.S.; Davison, A.G.; O'Driscoll, R.; Davison, A.; Elliott, M.; Howard, L.; Wedzicha, J.; Mackway-Jones, K.; Jenkins, P.; Kishen, R.; Levy, M.; Perrott, S.; Mansfield, L.; Evans, A.; Panizzo, S.; Moore, F.; Whitmore, D.; Gibbs, S.; Martin, B.; Hinshaw, K., 2008:
BTS guideline for emergency oxygen use in adult patients

Balfour-Lynn, I.M.; Field, D.J.; Gringras, P.; Hicks, B.; Jardine, E.; Jones, R.C.; Magee, A.G.; Primhak, R.A.; Samuels, M.P.; Shaw, N.J.; Stevens, S.; Sullivan, C.; Taylor, J.A.; Wallis, C., 2009:
BTS guidelines for home oxygen in children

Lim, W.S.; Baudouin, S.V.; George, R.C.; Hill, A.T.; Jamieson, C.; Le Jeune, I.; Macfarlane, J.T.; Read, R.C.; Roberts, H.J.; Levy, M.L.; Wani, M.; Woodhead, M.A.; Lim, W.Shen.; Baudouin, S.; George, R.; Hill, A.; Jamieson, C.; Le Jeune, I.; Macfarlane, J.; Read, R.; Roberts, H.; Levy, M.; Wani, M.; Woodhead, M.; Roberts, H.; Lim, W.S.; Woodhead, M.A.; George, R.; Le Jeune, I.; Wani, M.; Le Jeune, I.; Wani, M.; George, R.; Lim, W.S.; Lim, W.S.; Roberts, H.; Hill, A.; Baudouin, S.; Baudouin, S.;, 2010:
BTS guidelines for the management of community acquired pneumonia in adults: update 2009

Shields, M.D.; Bush, A.; Everard, M.L.; McKenzie, S.; Primhak, R., 2007:
BTS guidelines: Recommendations for the assessment and management of cough in children

Homes, S.; Nabil, J.; Johnson, N.; Jarad, N.; Pantin, C.; Jarad, N.; Jarad, N.; Baldwin, D.; Mahadeva, R.; Johnson, N.; Pantin, C.; Jarad, N.; Banham, S.; Mahadeva, R.; Harvey, J., 2008:
BTS statement on criteria for specialist referral, admission, discharge and follow-up for adults with respiratory disease

Anonymous, 2007:
BTS statement on malignant mesothelioma in the UK, 2007

Falconi, C.; López-Olvera, J.Ramón.; Gortázar, C., 2011:
BTV infection in wild ruminants, with emphasis on red deer: a review

Davtyan, H.; Hovakimyan, A.; Zagorski, K.; Davtyan, A.; Petrushina, I.; Agdashian, D.; Murthy, V.; Cribbs, D.H.; Agadjanyan, M.G.; Ghochikyan, A., 2015:
BTX AgilePulse(TM) system is an effective electroporation device for intramuscular and intradermal delivery of DNA vaccine

Alejandro, S.; Valdés, H.; Manero, M-H.; Zaror, C.A., 2012:
BTX abatement using Chilean natural zeolite: the role of Brønsted acid sites

Ye, C-Lei.; Xie, P-Hua.; Qin, M.; Ling, L-Yi.; Zheng, N-Na.; Liu, W-Bin.; Huang, Z-Zhao., 2014:
BTX monitoring nearby main road traffic in Guangzhou

Yucesoy, C.A.; Emre Arıkan, Önder.; Ateş, F., 2014:
BTX-A administration to the target muscle affects forces of all muscles within an intact compartment and epimuscular myofascial force transmission

Nixdorf, D.R., 2012:
BTX-A for persistent myofascial TMD pain: interpreting a small clinical trial with negative results

Saha, S.; Raghava, G.P.S., 2008:
BTXpred: prediction of bacterial toxins

Kimura, H.; Sato, Y.; Tajima, Y.; Suzuki, H.; Yukitake, H.; Imaeda, T.; Kajino, M.; Oki, H.; Takizawa, M.; Tanida, S., 2011:
BTZO-1, a cardioprotective agent, reveals that macrophage migration inhibitory factor regulates ARE-mediated gene expression

Yukitake, H.; Kimura, H.; Suzuki, H.; Tajima, Y.; Sato, Y.; Imaeda, T.; Kajino, M.; Takizawa, M., 2011:
BTZO-15, an ARE-activator, ameliorates DSS- and TNBS-induced colitis in rats

Yukitake, H.; Kimura, H.; Tajima, Y.; Sato, Y.; Suzuki, H.; Kajino, M.; Tanida, S.; Takizawa, M., 2013:
BTZO-2, an antioxidant response element-activator, provides protection against lethal endotoxic shock in mice

Holden, C., 1989:
BU Takes Over School District

Fine, B.J., 1989:
BU "Takeover" of Chelsea Schools

Agyin, J.K.; Santhamma, B.; Nair, H.B.; Roy, S.S.; Tekmal, R.R., 2010:
BU-32: a novel proteasome inhibitor for breast cancer

Khroyan, T.V.; Wu, J.; Polgar, W.E.; Cami-Kobeci, G.; Fotaki, N.; Husbands, S.M.; Toll, L., 2015:
BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice

Bolanos-Garcia, V.M.; Blundell, T.L., 2011:
BUB1 and BUBR1: multifaceted kinases of the cell cycle

Davidson, B.; Nymoen, D.Andre.; Elgaaen, B.Vilming.; Staff, A.Cathrine.; Tropé, C.G.; Kærn, J.; Reich, R.; Falkenthal, T.E.Hetland., 2014:
BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma

Tipton, A.R.; Wang, K.; Link, L.; Bellizzi, J.J.; Huang, H.; Yen, T.; Liu, S-Tao., 2011:
BUBR1 and closed MAD2 (C-MAD2) interact directly to assemble a functional mitotic checkpoint complex

Lira, Régia.C.P.; Miranda, F.A.; Guimarães, Márcia.C.M.; Simões, R.T.; Donadi, E.A.; Soares, C.P.; Soares, E.G., 2010:
BUBR1 expression in benign oral lesions and squamous cell carcinomas: correlation with human papillomavirus

Rizzardi, C.; Torelli, L.; Barresi, E.; Schneider, M.; Canzonieri, V.; Biasotto, M.; Di Lenarda, R.; Melato, M., 2011:
BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival

Xu, P.; Raetz, E.A.; Kitagawa, M.; Virshup, D.M.; Lee, S.Hyun., 2013:
BUBR1 recruits PP2A via the B56 family of targeting subunits to promote chromosome congression

Luhmann, C.C.; Ahn, W-Kyoung., 2007:
BUCKLE: a model of unobserved cause learning

Larget, B.R.; Kotha, S.K.; Dewey, C.N.; Ané, Cécile., 2011:
BUCKy: gene tree/species tree reconciliation with Bayesian concordance analysis

Dakshinamurthy, A.; Nyswaner, K.M.; Farabaugh, P.J.; Garfinkel, D.J., 2011:
BUD22 affects Ty1 retrotransposition and ribosome biogenesis in Saccharomyces cerevisiae

Morita, M.; Terada, T.; Nakamura, S.; Shimizu, K., 2011:
BUDDY-system: A web site for constructing a dataset of protein pairs between ligand-bound and unbound states

Fitzpatrick, J.M.; Kirby, R.S., 2008:
BUF in Sicily

Hector, A.; Bell, T.; Hautier, Y.; Isbell, F.; Kéry, M.; Reich, P.B.; van Ruijven, J.; Schmid, B., 2011:
BUGS in the analysis of biodiversity experiments: species richness and composition are of similar importance for grassland productivity

Perez-Pepe, M.; Slomiansky, V.; Loschi, M.; Luchelli, L.; Neme, M.; Thomas, Mía.Gabriela.; Boccaccio, G.Lidia., 2013:
BUHO: a MATLAB script for the study of stress granules and processing bodies by high-throughput image analysis

Anonymous, 1948:
BULBAR palsy or amyotrophic lateral sclerosis

Mahajan, S.M.; Burman, P.; Newton, A.; Heidenreich, P.A., 2018:
A Validated Risk Model for 30-Day Readmission for Heart Failure

Tweddell, L., 2007:
BUPA blurs boundaries in a new NHS ward deal

Wynnd, H.L., 1937:
BUREAU OF EPIDEMIOLOGY: CALIFORNIA STATE DEPARTMENT OF PUBLIC HEALTH: Report for the Month of June, 1937

Anonymous, 1946:
BURGERSPITAL of Basle; a landmark in municipal hospital building

Jaiprakash, B.; Chandramohan; Reddy, D.Narishma., 2006:
BURN WOUND HEALING ACTIVITY OF Euphorbia hirta

Lee, Y.H.; Ghohestani, R.F., 2011:
BURNS and ERUPTS: novel mnemonics for detection of squamous cell carcinoma and basal cell carcinoma

Persheyev, S.; Fan, Y.; Irving, A.; Rose, M.J., 2011:
BV-2 microglial cells sense micro-nanotextured silicon surface topology

Luo, X.; Ge, C.; Ren, Y.; Zhou, J.; Li, X.; Yan, R.; Zhang, C., 2009:
BV2 enhanced the neurotrophic functions of mesenchymal stem cells after being stimulated with injured PC12

Li, W.; Li, B.; Giacalone, N.J.; Torossian, A.; Sun, Y.; Niu, K.; Lin-Tsai, O.; Lu, B., 2012:
BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro

Anonymous, 2012:
BVA Congress to move to the London Vet Show

Anonymous, 2012:
BVA Council calls for more transparency on RCVS governance review

Anonymous, 2010:
BVA Council updated on OV negotiations

Anonymous, 2014:
BVA President calls for vets to be at the heart of food supply chain initiatives

Anonymous, 2011:
BVA President expresses concern about delay to badger cull in Wales

Anonymous, 2014:
BVA President highlights concerns about OV tendering

Anonymous, 2011:
BVA President highlights concerns about surveillance

Anonymous, 2014:
BVA President mans up for hantavirus research project

Anonymous, 2013:
BVA President warns against 'false economies' in surveillance

Anonymous, 2012:
BVA and BCVA highlight concerns about surveillance

Anonymous, 2014:
BVA appoints a new chief executive

Anonymous, 2014:
BVA backs new badger culls as Badger Trust wins right to appeal

Anonymous, 2014:
BVA calls for 'significant changes' to pilot badger culls

Anonymous, 2013:
BVA calls for a single national equine database

Anonymous, 2012:
BVA calls for further review of pedigree breed standards

Anonymous, 2011:
BVA calls for more investigation of welfare abuse at abattoir

Anonymous, 2011:
BVA calls for rabbit welfare code

Anonymous, 2013:
BVA clarifies eye scheme examinations